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1. Respiratory system. 
The respiratory system is essential for respiration, blood oxygenation and 
carbon dioxide removal 1.  
This system consists of two functional elements: a system of ducts and 
cavities, conducting zone, that allows air to reach the sites of gas 
exchange, and a second element is the respiratory portion where gas 
exchanges occur. The conduction system includes the nasal cavity, 
paranasal sinuses, pharynx, larynx, bronchi and bronchioles.  
Structurally, the respiratory system can be divided into upper respiratory 
system and lower respiratory system (Fig.1). 
 
 
Figure 1. 
Schematic representation of the organization of respiratory system. 
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1.1 Upper respiratory system. 
The upper airways consist the nose, nasal cavity, paranasal sinuses, 
nasopharynx and pharynx, that filter, heat and humidify the air inhaled 
through the nostrils. These cavities are coated with a respiratory 
epithelium, a pseudostratified ciliated columnar epithelium, comprised of 
two cell types, mucus goblet cells, which secrete mucus which traps the 
particulate material and main cells, equipped with cilia that move the thin 
layer of mucus. 
1.2 Lower respiratory system. 
The next segment is the lower airways, that includes the larynx, trachea, 
bronchi and lung. The trachea (or windpipe) is a tubular passageway for 
air that branches repeatedly to form approximately 14 generations of 
conduits. The trachea begins at the level of the sixth cervical vertebra and 
ends in the mediastinum at the level of the fifth thoracic vertebra, where 
trachea bifurcates into the right and left primary bronchus, which carry the 
air into the lungs. The mucosa of trachea consists of an epithelial layer of 
pseudostratified ciliated columnar epithelium and an underlying layer of 
lamina propria that contains elastic and reticular fibres. The epithelium 
consists of ciliated columnar cells, goblet cells, that reach the luminal 
surface, and basal cells. 
At superior border of the fifth thoracic vertebra, the trachea divides into a 
right and left primary bronchus, which goes, respectively, into a right and 
left lung.  
In each lung, the primary bronchi (named also extra-pulmonary bronchi) 
branch into bronchi with a smaller diameter, secondary (lobar) bronchi, 
which form the bronchial tree. The secondary bronchi divide to form 9-10 
tertiary (segmental) bronchi in each lung (intra-pulmonary bronchi). Each 
bronchus branches repeatedly in smaller bronchi named sub-segmental 
bronchi that branch into bronchioles. Bronchioles, in turn, branch 
repeatedly, and the smallest ones branch into even smaller tubes called 
terminal bronchioles. 
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These bronchioles contain Clara cells, columnar, non-ciliated cells 
interspersed among the epithelial cells. These cells are source of Clara 
cell secretory protein (CCSP) and release surfactant apoproteins, 
proteases, antimicrobial peptides, several cytokines and chemokines, and 
mucins to the extracellular fluid lining the airspaces 2. 
As the branching in the bronchial tree proceeds, several morphological 
changes occur. The mucosa epithelium goes from pseudostratified ciliated 
columnar in the main bronchi, lobar and segmental bronchi to ciliated 
simple columnar epithelium with some goblet cells in larger bronchioles, to 
mostly ciliate simple cuboidal epithelium without goblet cells in smaller 
bronchioles, to mostly non-ciliated simple cuboidal epithelium in terminal 
bronchioles (Fig. 2).  
 
 
 
Figure 2. 
The transition of the organization of ultrastructure of respiratory epithelium (from D. 
Kaminsky, Netter Collection of Medical Illustrations: Respiratory System 
3
). Figure 
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showing the appearance of pseudostratified columnar, cuboidal and squamous epithelial 
tissues from bronchi to bronchioles and alveoli, respectively (Ep: Epithelium; BM: Basal 
Membrane; SM: Sub Mucosa: FC: Fibro-Cartilage Layer). In the lower panel, shown is 
haematoxylin and eosin staining of the histological section of the respiratory epithelium in 
bronchi, terminal bronchioles and alveoli. Magnification 1000X. 
 
1.3 Respiratory units. 
Terminal bronchioles subdivide into microscopic branches called 
respiratory bronchioles that in turn subdivide into several alveolar ducts, 
which consist of simple squamous epithelium. Around the alveolar ducts 
are numerous alveoli, consisting of simple squamous epithelium and 
supported by the alveolar sac, an elastic basal membrane. The cells that 
constitute the alveoli are Type I alveolar cells, squamous cells, and Type II 
alveolar cells, or septal cells which are cuboidal epithelial cells and secrete 
alveolar fluid. Moreover, associated with the alveolar wall are alveolar 
macrophages (dust cells). These cells of the alveolar wall, with the 
epithelial basement membrane, capillary basement membrane and 
endothelial cells form the respiratory units, where the gases exchange 
take place. 
 
1.4 Microscopic anatomy of the lower airways. 
Even though the cells composition of the airways is different from upper to 
lower airways, the basic structure of the airway mucosa is well preserved: 
its cross section consists of five layers: epithelium, basement membrane, 
sub-epithelial layer, submucosa and adventitia 4. 
 
1.4.1 Tracheal and Bronchial Airways. 
The epithelium from trachea through the small bronchi is pseudostratified 
and columnar. Cell types present are: 
Ciliated epithelial cells, the most present and readily identifiable cells in 
the conducting airway wall. These structural cells have about 200 cilia 
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each that beat (about 1000 times/minute) in the liquid phase on epithelial 
surface, playing an essential role in clearance. These cells are more 
abundant in the lower portion of trachea. 
Goblet cells, are more present in the large airway and become 
progressively rarer in smaller bronchi and all but absent in bronchioles. 
These cells secrete mucus.  
Serous cells, represent 3% of respiratory epithelium cells and present 
microvillus and apical compartments containing liquid secretory serous. 
Clara cells, are the other secretory cells, with rounded surface and short 
apical microvillus. These cells are confined to peripheral airways where 
secrete surfactant with the aim of lung defence 5. 
Epithelium is pseudostratified and columnar. Epithelial cells interact and 
interconnect with one another through adhering junctions, tight junction 
and gap junction, to preserve the epithelial barrier function. 
The basement membrane is acellular and composed by extracellular 
matrix. Airway epithelial cells are attached to the basement membrane 
through proteins including type IV collagen, fibronectin, entactin, laminin 
and proteoglycans. This matrix has been exposed to constant remodelling, 
with formation and degradation of extracellular matrix proteins, due to the 
matrix metalloproteinases (MMPs). 
In the underlying layer is present a sub-epithelium with an extensive 
vascular and capillary network. 
The submucosa present smooth muscle, glands and lymphoid tissue 6.  
 
2. Chronic Obstructive Pulmonary Disease (COPD). 
2.1 Aetiopathogenesis. 
Chronic obstructive pulmonary disease (COPD) is an inflammatory 
disease of the airways, characterised by a progressive and not fully 
reversible limitation of expiratory airflow during forced expiration.  
COPD predominantly affects small airways (conducting airways with 
diameter <2 mm). This is due by an increase in resistance in the small 
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conducting airways and by an emphysematous destruction of lung elastic 
tissue. 
According to The Global Initiative for Chronic Obstructive Lung Disease 
(GOLD), symptoms consist of a cough, sputum production, or dyspnea 
and airflow limitation, confirmed by spirometry. Moreover, staging ranges 
from Stage I, Mild COPD (FEV1 Forced Expiratory Volume /FVC Forced 
Vital Capacity < 70%), to stage III, Severe COPD (FEV1 < 30% predicted) 
7. 
COPD is a multi-faceted disease and there are two main forms of COPD: 
chronic bronchitis, which involves a long-term cough with mucus, and 
emphysema, which involves the destruction of the lungs over time. Most 
people with COPD have a combination of both conditions. 
COPD is a major cause of death worldwide, with a prevalence estimated 
in 2006 at 10% of the general population and up to 50% in heavy smokers 
8 and further increases in its prevalence and mortality are expected in the 
coming decades 9. In COPD can be contemporary present a mixture of 
several airway disease: chronic bronchitis, emphysema, asthma and 
pulmonary hypertension and the relative contributions of which vary from 
person to person. 
This is accompanied by an abnormal inflammatory response against 
inhaled particles and gases in the lung, that establish increased mucus 
production and accumulation in the lumen of small airways; reduced 
mucociliary clearance, and increased permeability of the airspace 
epithelial barrier associated with early cell death. 
COPD is mainly associated with cigarette smoke (CS) exposure, indeed 
smoke is traditionally considered a well-known cause of airway and oral 
tissue damage, as well one of the five leading risk factors for mortality in 
the world 10. Exposure to pollutant and to biomass fuels is also 
increasingly considered a cause of COPD worldwide. Actually, only 
smoking cessation is the unique intervention capable of reducing the 
decline in lung function in patients affected by COPD. 
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CS induces chronic airway inflammation, through activation of both, 
structural and inflammatory cells within the lung and also peripheral 
inflammatory cell infiltration 11. Several studies have been reporting that 
smokers have from two to threefold increase in the rate of decline in lung 
function compared with non-smokers. However, although CS stimulates 
abnormal and persistent inflammation reaction, this occurs only in a 
minority of smokers; COPD development could therefore depend on 
individual susceptibility 12. 
 
2.2 Inflammation in COPD. 
The inflammatory reaction is principally localised in the small airways, 
where exposure to air pollution activates an inflammatory cascade 
resulting in the production of a number of potent cytokines and 
chemokines which play a critical role in the induction of chronic 
inflammation and subsequent tissue destruction. In COPD pathogenesis 
are involved many cells types: both innate and adaptive immune 
responses mediators, including airway and alveolar epithelial cells, 
endothelial cells, and fibroblasts. Even epithelial cells take part in this 
contest, producing  inflammatory mediators, including tumour necrosis 
factor (TNF) α, interleukin (IL)-1 β, IL-6, granulocyte-macrophage colony–
stimulating factor (GM-CSF), and CXCL8 (IL-8) and transforming growth 
factor (TGF) β. Macrophages, neutrophils, eosinophils, dendritic cells and 
T lymphocytes contribute to determining increasing inflammation, oxidative 
stress, cell death, impaired cell repair, protease/anti-protease imbalance, 
and destruction of the extracellular matrix 13. 
 
3. EMTU (Epithelial-Mesenchymal Trophic Unit). 
In the small airways there are many cell type that contribute to performing 
the numerous function of the respiratory system. These functions, in 
addition to air exchange and filter, include differentiation during lung 
growth, repair of damaged tissue, and regulation of the inflammatory 
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response. Evans and co-worker 14 have demonstrated that in the airway 
wall a thin layer of fibroblasts makes contact with epithelial basal lamina. 
This area is close to the epithelial/environmental interface and consists of 
the epithelial cells and the subtending fibroblasts along with their 
associated nerves and extracellular matrix. This epithelial-mesenchymal 
trophic unit (EMTU) establish a means of cellular communication between 
matrix and cells and between the cells themselves. Gap junctions are 
present and connect one cell to the next; the tight junctions (zonula 
occludens) prevent the passage of material across the cellular layer 
through intercellular spaces, forming a continuous belt (zonula). This 
arrangement ensures that substances can only pass through the layer of 
cells by diffusion or transport through their apical membrane. 
Tight junctions may achieve a direct signalling in this structure in which the 
function of epithelium might be coordinated by members of this unit, so as 
to organise components of the inflammatory as well as the repair and 
remodelling processes. 
Therefore, EMTU consists of opposing layers of epithelial and 
mesenchymal cells, with extracellular matrix and nerve fibres, in which 
fibroblasts are clearly involved in the airway remodelling and wound repair, 
when EMTU undergoes several stimuli and external noxious. For example, 
in asthma, sub-epithelial myofibroblasts have been shown to be increased 
in response to allergen 15. CS reduces cross-linking between fibroblast 
inhibiting the release of TGF-β, fibronectin, and PGE2 (Prostaglandin E2) 
16 
and inducing apoptosis through oxidative stress 17 (Fig. 3).  
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Figure 3. 
Epithelial-mesenchymal transition in EMTU which is subject to stressors. (From 
Oluwaseun et al 2014 
18
). 
 
Indeed, in COPD, where smoke is the main risk factor, the airway 
epithelium undergoes squamous, goblet cell metaplasia 19 and 
mesenchymal cells respond properly to epithelial cells injury. 
Exacerbation of COPD is correlated with airway remodelling because this 
consists in airway wall thickening by fibrosis and/or emphysema. Many 
studies speculate on the involvement of growth factors and matrix 
metalloproteinases (MMPs). High levels of Prostaglandin E2 and MMP-2 
correlate with the severity of airflow limitation in stable COPD 20 and 
genetic factors, such as MMPs haplotypes play a role in the disease 
severity 21. 
 
3.1 EMTU remodelling in COPD. 
As a result of the accumulation of inflammatory mucous in the lumen and 
infiltration of the wall by innate and adaptive inflammatory immune cells, in 
advanced stages of COPD the repair and remodelling processes occur. 
The fibroblasts of the EMTU, are involved in the increase of small airway 
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wall thickness. Indeed, fibroblasts are an important source of growth 
factors, extracellular matrix proteins and metalloproteases that remodel 
the interstitial space of the airway and alveolar tissue. The volatile 
compounds of CS are able to decrease the normal ability of the 
mesenchymal cell to respond properly to epithelial stimuli. Establishing, in 
this way, a failed lung repair 17.  
In COPD patients, the risk of lung cancer is increased by 4-5 fold, implying 
that similar mechanisms may be involved in the pathogenesis of COPD 
and lung cancer 22, in which epithelial cells lose their cell polarity and cell-
cell adhesion, and gain migratory and invasive properties to become 
mesenchymal-like cells.  
The relationship between EMTU remodelling in severe COPD and 
Epithelium-Mesenchymal Transition (EMT) was previously demonstrated: 
increased expression of EMT markers and reduced expression of 
epithelial junction molecules in the airways of smokers, and in particularly 
with COPD were shown 23,24. It has been proposed a common genetic 
susceptibility to COPD and lung cancer, such as a polymorphism that are 
expressed in airway epithelium. Also several molecular pathways are 
shared by chronic inflammation in COPD and tumorigenesis: the 
transcription factor STAT3, which is activated in COPD lung, is also 
expressed in lung adenocarcinomas 
25
; the involvement of NF-kB, 
implicated in tumor growth; TGF-β and MMP may promote the EMT 
transition; finally the reduction of expression of antioxidant mediators, that 
increase the oxidative stress 26. 
 
4. In vitro models of COPD. 
There are different models to mimic COPD pathogenesis, both in vivo and 
in vitro. 
Regarding in vivo models, the most common approaches in animal studies 
consist in the inhalation of noxious stimuli, (i.e., whole-body cigarette 
exposure system 27) or the tracheal instillation of tissue-degrading 
enzymes to induce emphysema-like lesions and gene-targeting 28. Among 
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laboratory animals, mice represent the most favored to study COPD, 
particularly concerning the immune system, because they permit to 
manipulate gene expression; otherwise, at least 6 months of smoke 
exposure are required to produce structural and physiological changes 
consistent with emphysema 29. Moreover, it is difficult to assess lung 
function and there are many differences, both anatomical and functional, 
between the murine and the human respiratory tract 30 31. Furthermore, 
concerning the animal models to test drugs, many of these fail to show 
efficacy and safety when advanced from animal studies to human clinical 
trials. 
In order to verify the responses to main environmental stimuli, involved in 
COPD progression, cell culture methods are widely used. Primary cells, 
obtained ex vivo and immortalized cell lines, both from carcinoma and/or 
transformed cell, can be used with the advantage of understanding the 
cellular and molecular process of disease, as well as, a high level of data 
reproducibility. 
Cell cultures provide appropriate standard model systems, but they grow 
in monolayer and in an artificial environment; therefore, they are not able 
to reproduce the cell and tissue physiology accurately. In contrast, three-
dimensional (3D) cell cultures produce a growth environment that mimics 
the native tissue as closely as possible, allowing an improvement in 
viability, morphology, proliferation, differentiation, response to stimuli and 
cell-cell communication. 3D cell cultures provide more accurate cell 
polarization and establish the cell–cell and cell–ECM (extracellular matrix) 
interactions that are not completely modelled in 2D culture. 
In 3D co-cultures of epithelial and mesenchymal cells in collagen gel, 
Zhang and colleagues have developed achieve an EMTU system, which 
reproduce the small airway organization in which epithelial cells are an 
important regulator of airway remodelling after cell damage exposition; 
indeed 3D cultures reproduce tissue- and organ-level pathophysiology in 
vitro 32.  
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Given these consideration, the choice of material for the scaffold, the 
source of cells, and the actual methods of culture, which vary considerably 
according to the tissue of study, assume great importance. Moreover, 3D 
cells have greater stability and longer lifespans to allow more appropriate 
long-term studies 33. Indeed, 3D culture techniques provide an organotypic 
culture that allow the real-time study of mammalian tissues. 
 
4.1 Bronchial epithelial 3D Outgrowth cultures. 
Conducting airways of the lung are composed by a highly specialized 
epithelium with varies structures and functions. Normal bronchial 
epithelium contains ciliated epithelial cells, secreting cells, and basal cells 
that can proliferate and differentiate into each of the three major cell types 
34.  
The 3D outgrowth model allows cells to re-establish mutual contacts and 
specific microenvironments that permit them to express a tissue-like 
phenotype. Indeed, in this culture model, in which are reproduced airways, 
cells form a pseudostratified layer in the air-liquid interface and can be 
used to study properties of the human airways, as well as to mimic 
heterotypic cellular interactions. 
Furthermore, The 3D culture system shows improvements in several fields 
in order to study the basic biological mechanisms like: cell number 
monitoring, viability, morphology, proliferation, differentiation, response to 
stimuli, cell-cell communication, migration and invasion of tumor cells into 
surrounding tissues, angiogenesis stimulation and immune system 
evasion, drug metabolism, gene expression and protein synthesis, general 
cell function and in vivo relevance 35.  
Moreover, this 3D organotypic model represents a breakthrough in studies 
of biological mechanism and particularly, in this case, is an important tool 
to evaluate the airway epithelial defence mechanisms, to study effects of 
toxins, cancer progression, and in addition, can be used to test new drugs 
and study their effects on ‘‘normal’’ or ‘‘preneoplastic’’ epithelia 36. 
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4.2 Cigarette smoke extract (CSE). 
COPD was initially recognized in 1821. COPD develops most commonly in 
people with a history of cigarette smoking and/or prolonged exposure to 
air pollutants. Indeed the cigarette smoking has been firmly established as 
the most important risk factor for the development of COPD. But the 
influence of others risk factors was still not clarified. The reason because 
some people develop COPD over others is under study. 
There are many works that use different approaches to mimic the stimuli 
that cause COPD. The in vitro methods directly assesses the cellular 
response exposing cells to smoke 37, oxidants 38, fine particles 39 and 
proteolytic enzymes 40. 
The most common exposure model for the study of the development of 
COPD is the generation of cigarette smoke extract (CSE). The most 
abundant component of smoke is nicotine, but a wide kind of different 
compounds derive from the combustion of tobacco. CSE is a concentrated 
complex of thousands of chemicals that consist of a particulate (polycyclic 
aromatic hydrocarbons and tobacco-specific nitrosamines, TSNAs) and a 
gas phase (formaldehyde, acrolein, and hydrogen cyanid). It has been 
established that the particulate phase is associated with cancer and, 
instead, the gas phase with COPD 41.  
The CSE is normally obtained, using a smoking machine, by the bubbling 
of CS in the medium; which is directly or diluted added to bronchial or lung 
cell cultures. The advantage of this method is that it captures the both 
particulate and gas phases; but remains not completely unknown the 
exact quantity of gas and chemicals present in the suspension. Although 
the smoke is constituted by many chemicals and additives, of which 
several are volatile, CSE is the most useful model in order to study the 
mechanism by which smoke induces direct lung damages. Indeed, CSE 
consists of several components that are able to pass through the mucus 
layer to reach epithelial cells, where induces DNA damages, cellular 
senescence, the increase of release of growth factors and cytokines, 
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production of metalloproteases and mucin secretion, reduction of cilia beat 
frequency and proliferation 42.   
The exposure to smoke directly impairs the lung, inducing oxidative stress, 
due to the action of toxic substances which are able to induce, for 
example, a glutathione depletion 43. Moreover, CSE causes inflammatory 
events because of the release of pro-inflammatory mediators and then the 
recruitment of cells of immune system, which enhance the inflammatory 
response. Indeed, the chronic inflammation in COPD is due to the 
repeated and progressive activation of immune cells. Several data support 
the hypothesis that exposure to CSE cause inflammatory airway events, 
considering that it has been shown that CSE may promote inflammatory 
cytokine and chemokine production in airway epithelium both in vitro 44–46 
and in vivo 47 models. 
 
5. Heat Shock Proteins. 
The Heat Shock Proteins (Hsps) are evolutionarily conserved proteins, 
present in the cells of all organisms, eukaryotes and prokaryotes, whose 
expression can be induced by different types of environmental stressors, 
such as disease states, hypoxia, ischemia, hyperoxia, exposure to toxic 
and carcinogenic factors 48. Many Hsps are part of the cellular 
chaperoning system, actually the primary function of Hsps appears to 
serve as molecular chaperones, indeed, they are essential for the control 
of protein homeostasis and the maintenance of correct and functional 
conformation of proteins and of nascent polypeptides, preventing their 
aggregation and misfolding 49. The Hsps have also been assigned other 
functions, not necessarily related to homeostasis of proteins, such as the 
regulation of gene expression and DNA replication 50, cell differentiation 51, 
signal transduction 52 and inflammatory response 53, the process of 
carcinogenesis 54, senescence 55 and cell apoptosis 56. 
Traditionally, HSPs are regarded as intracellular proteins, with localization 
in the cytoplasm, mitochondria, endoplasmic reticulum, peroxisomes and 
in the nucleus. However, their presence has been demonstrated in several 
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sites in the extracellular environment, indeed, can be released from cells 
in a variety of circumstances and interact with adjacent cells or in some 
cases enter the bloodstream and are present in fluids such as blood, 
lymph and cerebrospinal fluids 57.  
The Hsps are generally grouped into classes, based on their peptide 
sequence homology, structure, or in the molecular weight. Therefore, it is 
possible to distinguish: Hsps with high molecular weight (with a mass 
greater than or equal to 100 kD), Hsp90 (with mass between the 81 and 
99 kD), Hsp70 (with a molecular weight between 65 and 80 kD), Hsp60 
(between 55 and 64 kDa), Hsp40 (between 35 and 54 kD) and small Hsps 
(having a mass less than or equal to 34 kD). Each of these families 
includes various isoforms (Table 1) 58. 
 
Name HUGO Name 
59
 
Old Name Mass 
(kDa) 
Main functions 
Super-
heavy 
DNAJC28 Sacsin ≥200 Prevents protein 
aggregation, helps 
protein folding. 
Heavy HSPH High MW; Hsp100 100-199 Prevents protein 
aggregation, helps 
protein folding. 
Hsp90 HSPC HSP86, 
HSP89A,HSP90A, 
HSP90N, HSPC1, 
HSPCA, LAP2, 
FLJ31884 
81–99 Protein folding, 
cytoprotection; 
intracellular 
signalling (e.g., 
steroid receptor); 
cell-cycle control. 
Hsp70 HSPA Chaperones, DnaK 65–80 Prevents protein 
aggregation, protein 
folding, 
cytoprotection and 
anti-apoptotic 
function. 
Hsp60 HSPD1 Chaperonins (groups 
I and II), Cpn60 and 
55–64 
35–54 
Prevention of protein 
aggregation, protein 
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CCT folding, 
cytoprotection, 
macrophage 
activator possibly 
through Toll-like 
receptor. 
Hsp40 DNAJA DnaJ 35-54 Protein folding and 
refolding  together 
with Hsp70/Hsc70. 
Small Hsp HSPE1 sHsp, alpha-
crystallins, Hsp10 
≤34 Protein folding 
together with Hsp60; 
modulation of 
immune system. 
Other  Proteases, 
isomerases, AAA+ 
proteins (e.g., 
paraplegin or 
SPG7, spastin or 
SPG4); α-
hemoglobin-
stabilizing protein 
Various  
Table 1. 
Subpopulations of Hsp chaperones (modified from Macario and colleagues, 2010 
55
) 
 
5.1 Chaperonopathies and Hsps in lung diseases.  
When a malfunctioning of chaperones occurs, due to structural damage or 
gene dysregulation, a condition known as Chaperonopathia persist.  
The chaperonopathies are pathological conditions associated with the 
impairment of one or more molecular chaperones and are classified 
etiologically as genetic or acquired, as by defect, excess or mistake. In 
chaperonopathies due to a genetic mutation or a post translational 
modifications, the chaperone is altered or abolished in its functions. On the 
other hand, in chaperonopathies by defect, excess or mistake, the 
alteration is in the quantity of the chaperone and in its level and type of its 
function (Table 2) 55.   
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Types of 
chaperonopathies 
Causes Condition 
Genetic Gene mutation, 
Hereditary, Congenital 
Motor neuropathies, ataxias, Bardet-
Bield and Williams syndromes; 
cardiomyopathies; endoplasmic 
reticulum pathologies 
55,60
 
Acquired By defect and 
By excess 
 
 
 
By mistake or 
collaborationism 
Aging due to pathological post-
translational modifications, such as 
oxidation, phosphorylation, acetylation, 
or glycation 
55,60
 
 
Autoimmune and inflammatory disease, 
cancer 
55,61
 
Table 2.  
Types of chaperonopathies and main features 
 
Mammalian cells produce endogenous stress proteins following a stimulus 
harmful and these can be also secreted outside or released from dying 
cells. Generally, Hsps have a protective role intracellularly but have 
potentially adverse effects when secreted outside cells (Table 3). Hsps are 
constitutively produced and released from cells and the levels are higher 
in response to trauma. When Hsps are secreted they can bind to the 
surface of adjacent cells, through receptors such as Toll-like receptors 
(TLRs) 2 and 4, CD40, CD91, starting the signal transduction cascade 62–
64. Indeed, Hsps have a powerful effect on the immune response. 
Regarding the extracellular role of some Hsps, because they are key 
factors in activation of immune system, a dysfunction of these proteins 
may lead to an inflammation condition and may play a central role in the 
pathogenesis of inflammatory diseases.  
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Stress protein 
 Protein function  
Intracellular                                    Extracellular 
Hsp27 Antideath Anti-inflammatory 
Hsp60 Chaperonin Pro-inflammatory 
Hsp70 Antideath Immunoregulatory, proinflammatory, 
neuronal survival 
Hsp90 Cell regulation Pro-immune, pro-metastatic 
Hsp110 Co-chaperone Pro-immune 
Grp78 ER (Endoplasmic Reticulum) 
chaperone 
Anti-inflammatory 
Grp94 ER chaperone Immunoregulatory 
Grp170 ER chaperone Pro-immune 
Table 3. 
Intracellular and extracellular properties of Hsps. Modified from Calderwood and 
colleagues, 2007 
57
. 
 
Actually, the involvement of Hsps in inflammatory disorders, such as lung 
disease, has been documented 65. In inflammatory lung diseases, the 
innate immunity is the first line of defence of the immune system, providing 
initial protection against various pathogens and infections. In this context, 
a large number of works have demonstrated that Hsps, such as Hsp60, 
Hsp70, Hsp90 and gp96, are involved in the activation and regulation of 
the immune signaling pathways. Hsps were seen to be implicated in 
antigen direct presentation and cross-presentation leading to CD8+  T cell 
activation, being a part of the endogenous pathway of antigen 
presentation through the MHC (major histocompatibility complex) class I 
molecules 66. Moreover, Hsps induce the maturation of dendritic cells by 
up-regulation of MHC class I and MHC class II 67 and are observed to 
have cytokine effects mediated by TLR (Toll-like receptors) 68 and protein 
kinases cascade activation 62. 
The leukocyte migration into alveolar space and the production of 
inflammatory mediators by epithelial cells play a critical role in pulmonary 
inflammation resulting in lung injury. In COPD, some Hsps were seen to 
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be related or overexpressed, such as HspB5, Hsp70 and Hsp27, which 
appear to be predominantly in extracellular space and may activate the 
Toll-like receptors and provoke inflammation 69–72. This could be due to the 
necessity to keep the proteostasis and the cellular homeostasis to 
counteract the oxidative stress, both in COPD smokers and non-smokers; 
conversely, Hsps may have not a cytoprotective properties when secreted 
outside from cells, such as Hsp60 65. 
   
5.2 Hsp60. 
The Hsp60 is a ubiquitous and highly conserved protein presents both in 
eukaryotes and prokaryotes, including pathogens 73. The human Hsp60 is 
a mitochondrial chaperone phylogenetically related to the bacterial protein 
GroEL 74. This chaperonin is constituted by wide double-loop complex and 
each of these loops is composed of 7 subunits of about 57 kDa, that 
contains three domains: an apical domain, which represents the binding 
site for polypeptides, an equatorial domain, which contains the binding site 
of ATP/ADP and an intermediate domain, which acts as a connector of the 
other domains (Fig. 4) 75,76.  
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Figure 4. 
Hsp60 monomer structure showing its three structural domains: apical in green, 
intermediate in yellow and equatorial in red. (from Cappello and colleagues, 2014 
76
). 
Hsp60 works in cooperation with Hsp10, its co-chaperonin, to assist protein folding of 
unfolded mitochondrial proteins by an ATP-dependent mechanism. 
 
Hsp60 is classically considered an intracellular chaperone and works, 
during the folding process, with Hsp10, its co-chaperone, and covers 
many essential roles in cells; being responsible for the protection of cells 
against all stressors is essential for cell survival 77. The typical localization 
of Hsp60 is the matrix of mitochondria, but numerous studies have shown 
its presence in extra-mitochondrial sites, such as the cytosol and plasma 
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membrane. Furthermore, this chaperon is present in the extracellular 
environment and bloodstream, where is able to interact with immune 
system cells and to stimulate cells at distant sites in the body. For this 
reason, Hsp60 was identified as a chaperokine. Indeed, Hsp60 may 
induce maturation of human monocyte-derived dendritic cells and T cell 
polarization and may trigger the monocyte and macrophage cells to 
synthetize pro-inflammatory cytokines, such as TNF-α, IL-12 and IL-15 
78,79. 
It has been proposed that the immunological characteristics of Hsp60 are 
due to the high degree of homology with prokaryotic Hsp60, as a failure of 
the mechanism of self-, not self-discrimination, inducing autoimmunity 74; 
determining the maintenance of inflammation in autoimmune 80 and 
chronic inflammatory disease 65. 
The Hsp60 secretion is an active mechanism that, among others, involves 
the exosomes pathways 81. 
 
6. Exosomes. 
Cell communication is imperative to live 82. Therefore, in order to maintain 
cellular homeostasis or to respond to pathogens in the extracellular milieu, 
cells often exchange information through direct cell-cell contact or by 
secretion of soluble factors. Abundant evidence has shown a newly 
identified mechanism of intercellular interaction through lipid vesicles, such 
as exosomes, in which phospholipid-enclosed vesicles are released into 
the extracellular environment that can bind the specific receptor to the 
target cells, and these vesicles are, frequently, internalized by recipient 
cells 83.   
As described by Pan in 1983, it was initially thought that exosomes could 
be a mechanism for shedding the cytoplasm in maturing sheep 
reticulocytes 84. Several recent studies provide further support to show that 
exosomes are extracellular small particles of 30-100 nm in diameter, which 
have an endosomal origin and are secreted by all cell types. Exosomes 
are also present in many body fluids such as blood, urine, cerebrospinal 
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fluid, breast milk, saliva, bronchoalveolar lavage fluid, ascitic fluid and 
amniotic fluid 85. Exosomes are released into the extracellular space after 
the merging of late endosomes with the cell membrane. Previously, early 
endosomes become part of multivesicular bodies (MVBs), which undergo 
a maturing process that provides a gradual change in protein composition 
of the vesicles (intraluminal vesicles, ILVs). During this maturation 
process, the vesicles accumulated in the MVBs, can have three potential 
outcomes: 1) they may merge with the lysosomes, causing protein content 
degradation (e.g., in the case of receptors); 2) they may constitute a 
temporary storage compartment; 3) they may blend with the plasma 
membrane, releasing exosomes. Therefore, exosomes correspond to the 
intraluminal vesicles of MVBs. MVBs merge with the plasma membrane, 
resulting in exocytosis of the vesicles contained in MVBs; as such, 
vesicles maintain the same topological orientation as the plasma 
membrane 82,86. 
The endosomal sorting complexes required for transport machinery 
(ESCRT) are involved in exosome biogenesis and in their loading. 
Different evidence sources support the idea that ESCRT could assist in 
the sorting of ubiquitinated cargo proteins at the endosome membranes. 
The ESCRT-associated protein ALIX (apoptosis-linked gene 2-interacting 
protein X) can regulate this function 
87
.   
Exosomes exhibit specific cell-type dependent content. Numerous studies 
are conducted to find the whole content of exosomes for the purpose of 
understanding them function and to exploit them as drug delivery, for 
instance.  
Generally, it seems plausible that the exosomes standard composition 
depend on parental cells condition, and contains lipids, nucleic acids, such 
as DNA, non-coding RNA, rRNA (Ribosomal RNA) and miRNAs 
(microRNAs) and proteins. 
It has been reported that the lipid composition is specifically sorted out in 
emerging exosomes and is enriched of cholesterol, phosphatidylcholine, 
sphingolipid ceramide and sphingomyelin that probably provide to stabilize 
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the bilayer membrane integrity in the extracellular milieu 88 and, in 
particular, sphingolipid ceramide play a key role in the budding of 
exosomes 89. 
The presence of mRNA 90 and miRNA 91 in exosomes vesicles indicate the 
activity in expression regulation in both recipient and donor cells, proof of 
horizontal transfer of genetic information. This has been showed 
frequently in immune system cell to aim to allow immunological function 92. 
Concerning the proteins composition, in exosomes are found different 
classes of these, strictly involved in vesicles trafficking, such as cell 
surface receptor or specific content of endocytic pathway (GTPases; 
annexins; flotillin, endosomal sorting complex required for transport, 
ESCRT, such as Alix; tumor susceptibility gene 101, TSG101; integrin and 
a number of tetraspanins such as CD9, CD53, CD63, CD81 and CD82, 
depending on the origin cell). On the other hand, are present important 
proteins to long distance communication, such as cytokine 93, hormones 
94, growth factors, transcriptional factors 95 and heat shock proteins 96,97 
(Fig. 5).  
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Figure 5. 
Biogenesis and content of exosomes comprising mRNA, DNA, microRNAs, proteins (ie, 
enzymes, growth factors, and cytokines), and transmembrane proteins of different kinds, 
including tetraspanins, annexin, and intracellular cell adhesion molecule (from 
98
). 
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Depending on the source cell and the content, many different functions 
have been attributed to exosomes. They are involved in cell-to-cell 
information transfer 99, immune response 100, inflammation 101, coagulation 
102, stem cell activation 103 and programmed cell death 104. Exosomes can 
participate in cellular responses against stress 105. It has been shown that 
exposing B-cell lines to heat stress results in a marked increase of Hsps 
expression by exosomes and in an increase in the quantity of exosomes 
produced 105. Recent studies have validated this hypothesis by 
demonstrating that specific members of the Hsp family, such as Hsp60, 
Hsp70 and Hsp90, can be secreted by cancerous cells via exosome 
pathway 81,96,106 (Fig. 6). Exosomal Hsps may have opposing roles, that is, 
immunosuppressing or immunostimulating effects. These different effects 
depend on the interaction between exosomal Hsps and cells or immune 
system components. 
Given that exosomes can mediate the transfer of specific molecules, they 
may play a role in intercellular transmission in disease pathogenesis, 
including tumour development, viral infections and neurological diseases 
107–110.  
 
 
Figure 6. 
Exosomal Hsps and mechanism of release from Campanella and colleagues, 2014 
111
.  
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As discussed in the introduction of this thesis, COPD is one of the leading 
causes of mortality and morbidity in the world and is rapidly increasing 
among the world population. The main risk factor for the disease is 
cigarette smoke (CS), which is linked to approximately 90% of COPD 
cases. CS acts as an inflammatory mediator inducing pulmonary 
inflammation by damaging the respiratory epithelial barrier. In the smoker’s 
lung, these mediators, together with infections, accentuate a milieu of 
chronic inflammation on patients with stable COPD, characterized by the 
presence of immune cells 65.  
Among the molecules involved in lung diseases, it has been already 
demonstrated 65 that several Hsps, such as Hsp60, have “cytokine-like” 
functions in different bronchial pathologies, such as COPD and lung 
cancer. In this context, our hypothesis is that Hsp60 could be released 
from the stressed bronchial mucosa into the bloodstream and may act as 
a cytokine, determining the activation of the immune cells and 
subsequently, influencing the exacerbation of inflammatory response.  
The main aims of this thesis were to find a further correlation between the 
chronic inflammation in COPD and Hsp60, to clarify which pathways are 
involved in Hsp60 export from bronchial epithelial cells and to investigate 
whether the extracellular Hsp60 might effectively cause activation of 
PBMC (peripheral blood mononuclear cells). 
In order to test our hypothesis, we assessed three different models that 
mimic COPD and the experimental design was developed as follow: 
1. Assessment of Hsp60 and its co-chaperone Hsp10 levels and 
localization in vivo (bronchial specimens obtained from smokers 
and non-smokers). 
 
2. Development of an in vitro monolayer model to reproduce the 
oxidative stress induced by CSE and subsequent evaluation of 
Hsp60 levels and localization. 
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3. Optimization of a three-dimensional ex vivo model to understand 
the mechanisms of the pro-inflammatory effects after CSE 
exposure. In this perspective, we investigated whether CS can 
modulate the expression of Hsp60 and trigger the release of this 
“chaperokine” as well as the release of other inflammatory 
cytokines. Furthermore, we investigated the effects of extracellular 
Hsp60 on monocyte-cytokines production. 
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Materials and Methods 
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1. Experiments in vivo. 
 
Method Antigen Type and 
source 
Clone Supplier Catalogue 
Number 
Dilution 
IHC, 
ICC, 
WB; IF  
 
Hsp60 Mouse 
monoclonal 
 
LK-1 Sigma-Aldrich, 
St. 
Louis, MO, USA 
 
H4149 1:400 (IHC, 
ICC, IF) 
1:2000 (WB) 
IHC, 
ICC 
Hsp10 Rabbit 
polyclonal 
Cpn10 StressGen 
Biotechnologies, 
Victoria BC, 
Canada, 
SPA-110 1:300 
WB Β-actin Mouse 
monoclonal 
HRP-
conjugated 
C4 Santa Cruz 
Biotechnology, 
Dallas, TX 
sc-47778 1:3000 
WB Alix Mouse 
monoclonal 
 
AIP1 Pharmingen (BD 
Biosciences, 
San Diego, CA 
611620 1:500 
WB Hsp70 Mouse 
monoclonal 
 
3A3 Santa Cruz 
Biotechnology, 
Dallas, TX 
sc-32239  
IF EGFR Mouse 
monoclonal 
 
0.N.26
8 
Santa Cruz 
Biotechnology, 
Dallas, TX 
sc-71034 1:500 
iF α-actinin Mouse 
monoclonal 
 
EA-53 Sigma-Aldrich, 
Milan 
A7811 1:300 
IF TJP1 Rabbit 
polyclonal 
ZO1 Sigma-Aldrich, 
Milan 
HPA00163
6 
1:200 
Table 4.  
Primary antibodies used for immunohistochemistry (IHC), immunocytochemistry (ICC), 
western blotting (WB), and immunofluorescent (IF).   
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1.1 Immunohistochemistry (IHC) 
Samples for immunohistochemistry were obtained from 19 subjects with 
normal lung function, among whom nine were current smokers (age= 
64±8; M:F=8:1) and 10 non-smokers (age= 65±9; M:F= 9:1).  
A standardized procedure 112 was followed for fiberoptic bronchoscopy 
and collection of bronchial biopsies. Using local anesthesia with lidocaine 
(4%) to the upper airways and larynx, a fiberoptic bronchoscope (Olympus 
BF10 Key-Med, Southend, UK) was passed through the nasal passages 
into the trachea and four bronchial biopsy specimens were taken from 
segmental and sub segmental airways. 
For histological analysis, the samples were embedded in Tissue Tek II 
OCT (Miles Scientific, Naperville, IL) and 6 mm thick cryostat sections 
were cut and processed for immunohistochemical analysis.  
The sections were rehydrated, at room temperature, by three sequential 
washing in PBS (Phosphate Buffered Saline pH 7.4), for five minutes 
each. Subsequently, the sections were immersed for 10 minutes in 
Sodium Citrate Buffer (pH 6) at room temperature for antigen exposing. 
After three washing with PBS  for 5 minutes, the sections were treated for 
5 minutes with Peroxidase Quenching Solution (reagent A of Histostain®-
Plus 3rd Gen IHC Detection Kit, Invitrogen) to inhibit any endogenous 
peroxidase activity. After that, another washing was carried out in PBS for 
5 minutes and then the sections were treated with a blocking protein 
(reagent B of Histostain®-Plus 3rd Gen IHC Detection Kit, Invitrogen) for 
10 minutes in order to block non-specific antigenic sites. Subsequently, 
the sections were incubated overnight with a primary antibody against 
human Hsp10 (Rabbit Anti-Cpn10 Polyclonal Antibody, StressGen 
Biotechnologies, Victoria BC, Canada, Cat. No. SPA-110, dilution 1:300), 
human Hsp60 (mouse anti-Hsp60 monoclonal antibody, Sigma, St. Louis, 
MO, catalogue no. H4149, dilution 1:400). After one washing with PBS for 
5 minutes, the sections were incubated with a universal biotinylated 
secondary antibody (Biotinylated Secondary Antibody reagent C 
Histostain®-Plus 3rd Gen IHC Detection Kit, Invitrogen) for 10 minutes. 
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After another washing with PBS for 5 minutes, the sections were 
incubated with streptavidin-peroxidase complex (Streptavidin-Peroxidase 
Conjugate reagent D Histostain®-Plus 3rd Gen IHC Detection Kit, 
Invitrogen) for 10 minutes. Following a further washing in PBS for 5 
minutes, the slides were incubated in the dark for 5 minutes using the DAB 
chromogen (diaminobenzidine) (DAB chromogen reagents E1 and E2 
Histostain®-Plus 3rd Gen IHC Detection Kit, Invitrogen). Nuclear 
counterstaining was obtained using hematoxylin (DAKO, Cat. No. S2020). 
Finally, the slides were prepared for observation with coverslips with an 
aqueous mounting solution. The observation of the sections was 
performed with an optical microscope (Leica DM 5000 B) connected to a 
digital camera (Leica DC 300F).    
Ten fields were examined in each slide and cell counting was performed at 
the same magnification. 
 
2. Experiments in vitro. 
2.1 Cells cultures. 
In this study immortalized normal bronchial epithelial cell line (16-HBE) 
and human mucoepidermoid bronchial carcinoma cell line (NCI-H292) 
were used. 
16-HBE is a cell line that retains the differentiated morphology and 
function of normal airway epithelial cells 113. 16-HBE cells were cultured in 
Dulbecco-modified Eagle’s medium (DMEM) with 10% heat-inactivated 
fetal calf serum (FCS) and supplemented with 2 mM glutamine, 50 U/ml 
penicillin, and 50 mg/ml streptomycin. 
NCI-H292, derived from a cervical node metastasis of a pulmonary 
mucoepidermoid carcinoma, were maintained in Roswell Park Memorial 
Institute (RPMI) 1640 Medium with 10% FCS and in the same way as 16-
HBE, supplemented with glutamine, penicillin and streptomycin. 
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Cell cultures were grown as monolayers attached to the culture flask and 
cultured at 37°C, 5% CO2 in a humidified incubator. Passage number of 
cells used in this study ranged from 12 to 35. 
 
2.2 Cigarette smoke extract (CSE). 
Kentucky 1R4F research cigarettes (University of Kentucky, Lexington, 
KY) were used in this study. 
CSE was prepared by modification of the methods of Carp and Janoff 114. 
The smoke from two cigarettes without filter was gurgled, for 60-70 sec, 
through 40 ml of serum-free DMEM or RPMI, for monolayer cell culture, or 
BEBM, for 3D outgrowth culture. A Buchner flask connected to a system 
acting as a vacuum-driven apparatus was used. Then, the resulting 
suspension was adjusted to pH 7.4 with concentrated NaOH and filtered 
through a 0.22 µm pore filter Syringe filter (Whatman, Fisher scientific), to 
remove bacteria and large particles, and was defined as 100% CSE. It 
was used immediately to treat cell cultures at different percentages and for 
different incubation times. 
 
2.3 Cell viability Assay (MTT). 
Preliminary analyses were performed to identify the best time point as well 
as the best CSE concentration. 
In order to study whether exposure to cigarettes smoking was or not 
associated with cytotoxicity, cell viability was assessed by reduction of the 
tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) to its insoluble formazan, which has a purple dye by 
mitochondrial enzymes associated with metabolic activity, indicating living 
cells 115. Briefly, cells were seeded in 96-well plates (6,000 cells/well) and 
were allowed to adhere overnight, then were treated with CSE (0-100%) 
for 24, 48 and 72 hours. 20 µL of fresh MTT solution (5 mg/mL) was 
dissolved in PBS and was added to the cells that were cultured for 5h at 
37ºC. After that, the medium was removed and 200 µL of DMSO solution 
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was added to dissolve formazan crystals. Therefore, absorbance was 
measured at 550 nm by a plate reader and the viability was set as 100% in 
non-treated cells.  
 
2.4 Total RNA Extraction and Retro Transcription PCR. 
RNA from both treated and untreated cells, was obtained, as previously 
described by Rappa and colleagues 116,  by the use of TRI Reagent© 
(Catalog Number T9424, Sigma-Aldrich, Saint Lois, MO), which is a 
mixture of guanidine thiocyanate and phenol that allow to isolate 
simultaneously RNA, DNA, and protein.   
Cells were seeding with density of 6 x 106 cells/25 cm2 and after treatment 
were detached and centrifuged at 300 x g, 4°C. Each cell pellet was 
homogenized in 1 ml of TRI Reagent© and subsequently centrifuged at 
12000 x g for 10 minutes at 4°C to remove the insoluble material. Then, 
0.2 ml of chloroform was added to the samples. After 15 minutes, the 
mixtures were centrifuged at 12000 x g for 15 minutes at 4°C, to separate 
the RNA phase from proteins and DNA, and RNA phase was transferred 
to a fresh tube and then 0.5 ml of isopropanol was added. After 10 
minutes, the samples were centrifuged at 12000 x g for 10 minutes at 4°C. 
The supernatant was removed and the RNA pellet was added to 1 ml of 
75% ethanol and then shaken. The mixture was centrifuged at 7500 x g for 
5 minutes at 4°C. Finally, we dissolute the air-dried RNA in 50μl of 
RNase/DNase-free H2O by repeated pipetting with a micropipette at 55–60 
°C for 10–15 minutes.  
The concentration of the RNA extract was determined using Thermo 
Scientific NanoDrop ND-2000 1-position Spectrophotometer (Thermo 
Scientific Massachusetts, USA). 
cDNA was synthesized, as described by Campanella and colleagues 117, 
using ImProm–II Reverse Transcriptase (Catalog Number A3800, 
Promega Corporation, Madison, WI, USA). To obtain 200 ng of cDNA, 
twenty microliters of mixed solution with RNA template, 0.5 µg Oligo(dT) 
primers, 6mM MgCl2, reaction buffer 5X, 1 µL dNTP (0.5 mM mixture of 
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dATP, dCTP, dGTP, and dTTP), 20U RNase inhibitor, 1 µL ImProm-II 
reverse transcriptase, and nuclease-free distilled water was incubated at 
25℃ for 5 minutes and then at 42°C for 90 minutes. To inactivate reverse-
transcriptase, the mixture was incubated at 70℃ for 15 minutes. 
Thereafter, cDNA was amplified using GoTaq® Flexi DNA Polymerase 
(Catalog Number M8291, Promega Corporation, Madison, WI, USA), using 
1.25U GoTaq Polymerase. Semi-quantitative PCR was performed by 
adding primers specific for human Hsp60 and β-actin, the latter was 
analyzed as a housekeeping gene internal control (Table 6). Reactions 
were carried out for 2 minutes of preheating at 95℃ and 35 repeated 
cycles of reactions at 95℃ for 1 minute, 60℃ for 1 minute, and 72℃ for 3 
minutes. A final incubation was done at 72℃ for 5 minutes, and the 
reaction was stopped at 4℃. The PCR product was visualized on 1.5% 
agarose gel with the SYBR stain (SYBR SafeTM DNA gel stain, 10,000X 
concentrated in DMSO- Invitrogen, Carlsbad, CA). 
Experiments were performed in triplicate. Quantitative measurements of 
bands were performed using the NIH Image J 1.40 analysis program 
(National Institutes of Health, Bethesda, MD) 116 
 
2.5 Immunomorphological analyses: immunocytochemistry and 
immunofluorescence. 
Cells were routinely photographed before and after treatment to observe 
any morphological changes occurring in the cells. 
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2.5.1 Immunocytochemistry (ICC). 
Analysis was performed on 16-HBE cells cultured on chamber slides and 
treated with 0, 5 and 10% of CSE for 24 hours. After culturing, cells were 
fixed with ice-cold methanol for 30 minutes, and, after rinse with PBS 
(three times for 5 minutes), permeabilized with 0.1% (v/v) Triton X-100 and 
0.1% sodium citrate in PBS for 5 minutes. Fixed cells were treated with 
Histostain®-Plus 3rd Gen IHC Detection Kit (Invitrogen), following 
manufacturer’s instructions, in the same way as immunohistochemistry 
(see above) . 
After incubation with blocking reagent for 10 minutes, cells were incubated 
with primary antibodies overnight at 4°C (anti-HSP60, LK1 clone, Sigma-
Aldrich; anti Hsp10 clone D8, Santa Cruz Biotechnology). Finally, cells 
were incubated with universal biotinylated secondary antibody and then 
with streptavidin-peroxidase complex for 10 minutes. Following a further 
washing with PBS for 5 minutes, the slides were incubated in the dark for 
5 minutes in the DAB chromogen. Haematoxylin was used for 
counterstaining. The positive reaction was observed using a light 
microscope (Leica DM5000B, Leica Microsystems, Heidelberg, Germany). 
Experiments were performed in triplicate. 
 
2.5.2 Double immunofluorescence (IF) in monolayer cell 
cultures. 
To assess the subcellular localization of the chaperonin Hsp60 and its 
possible co-localization with the EGF-Receptor (a plasma membrane 
marker), a double immunofluorescence was carried out. 
The immunofluorescence was performed as previously described by 
Marino Gammazza and colleagues 118. Briefly, 16-HBE cells were seated 
in 8-well microscope chamber slide at the density of ten thousand 
cells/well, cultured for 24 hours and then treated with CSE (0, 2.5, 5 and 
10%) for 24 hours. Cells were fixed with ice cold methanol for 30 minutes, 
washed three times with PBS pH 7.4 and then were incubated with 
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unmasking solution (tri-sodium citrate 10mM, 0.05% Tween 20, pH 6) for 
10 minutes at RT (room temperature, 24°C). After rinsing twice with PBS, 
the cells were blocked  with 3% (w/v) bovine serum albumin (BSA, Sigma 
Aldrich) for 30 minutes at RT and incubated with the first primary 
antibodies anti-EGF-R (clone 0.N.268, from Santa Cruz Biotechnology, 
Dallas, TX) diluted 1:500, overnight at 4°C. The day after, the cells were 
incubated with the second primary antibody anti-HSP60 (clone LK1, 
monoclonal antibody from Sigma-Aldrich, St. Louis, MO), diluted 1:500, 
overnight in a humidified chamber at 4°C. Once again, cells were 
incubated with fluorescent secondary mouse IgG antibody TRITC 
conjugated (from Sigma-Aldrich), diluted 1:250, for 1h at RT. Therefore, 
we used FITC conjugated rabbit IgG secondary antibody (from Sigma-
Aldrich), diluted 1:250, for 1h at RT in a moist chamber. The nuclei were 
counterstained with Hoechst 33342 (Sigma-Aldrich) for 15 minutes at RT. 
Finally, the slides were covered with drops of PBS and mounted with 
coverslips, using a drop of Vectashield (Vector, Burlingame, CA). Imaging 
was immediately performed with an upright fluorescent microscope Leica 
DM5000. The cell positivity of both markers (“Merge”) was assessed 
through the ImageJ Free software (NIH). 
 
2.6 Western blotting Analysis. 
The 16-HBE and H292 cells were cultured in T25 flask and treated once 
cells reach 70-80% confluence. On the basis of the results obtained by 
MTT assay, cells were treated for 4, 8, 16 and 24 hours with different CSE 
concentration (0, 2.5, 5, 10%). Cells were mechanically detached from 
flask and centrifuged at 222 x g for 5 minutes. The pellet was washed two 
times with PBS and then cells were lysed using radioimmunoprecipitation 
assay (RIPA) buffer, containing 50mM Tris/HCl,150mM NaCl,1% NP-40, 
1mM EGTA and supplemented with Protease Inhibitor Cocktail (Sigma-
Aldrich, USA) (1mM AEBSF, 1µM Aprotinin, 50µM Bestatin, 15µM E-64, 
20µM Leupeptin, 10µM Pepstatin A). The entire procedure was carried out 
on ice to prevent protein degradation. Cell lysates were then homogenized 
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by pipetting up and down several time on ice for 1 hour. To obtain only the 
whole protein suspension, lysates were centrifuged at 16,000 x g for 20 
minutes. The supernatant was collected and stored in new tubes at -20°C 
115.  
Total proteins concentration was determined using Bradford assay, which 
allow to measure protein concentration by comparing the absorbance 
value with a known value based on a calibration curve of bovine serum 
albumin (BSA). Finally, the absorbance at 550 nm was read. This 
preparation is referred to as “total-cell lysate”. 
A standard western blotting procedure was followed to separate protein 
using a 12% polyacrylamide gel (SDS-PAGE); in which equal amounts of 
protein (20 µg) were added to 4X Laemmli buffer and heated for 5 min at 
95 °C. Therefore samples were loaded in each well and transferred onto a 
nitrocellulose membrane (BioRad, Milan, Italy). The membranes were 
stained with Ponceau S to verify the quality of transfer and loading 
similarity. After blocking with 5% albumin bovine serum (Sigma Aldrich), 
membranes, with the spotted proteins, were analyzed to measure the 
protein levels, probing with specific primary antibodies for 12 hours 
followed by incubation with horseradish peroxidase-conjugated secondary 
antibody if necessary. The final detection was performed using the 
enhanced chemiluminescence (ECL) detection system, Western Blotting 
Detection Reagent (Amersham Biosciences, GE Healthcare Life Science, 
Milan, Italy), according to the manufacturer’s instructions. Membranes 
were then exposed to X-ray film from few second to 5 min and the film was 
analyzed. 
Densitometric analysis of the bands was evaluated and quantified using 
the NIH Image J 1.40 analysis program (National Institutes of Health, 
Bethesda, MD).  
Each experiment was performed at least three times. 
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2.7 Exosomes isolation from culture supernatant. 
Prior to each experiments, confluent cell monolayers were incubated in 
medium with serum exosomes–free (to avoid possible contaminations by 
bovine exosomes from the FBS) for 24 hours. 
The 16 HBE and H292 cells were grown under the conditions described 
above (see the section 2.1). Once the reached 70% to 80% of confluence 
they were treated with different concentration of CSE (0 and 10%) for 24 
hours. Eighty ml of conditioned medium from 80×106 were collected and 
then centrifuged (800 × g for 10 minutes at 4 °C) to eliminate cells and 
debris. The cell- and debris-free medium was collected on ice and 
centrifuged at 13,000 × g for 20 minutes at 4 °C to span down and 
eliminate small cellular debris and mitochondrial contaminants.  
To obtain exosomes from the 3D outgrowth culture supernatant, 
conditioned medium was collected every two days. It was filtered with 0.22 
µm pore filter in order to eliminate dead cells and large debris while small 
membranes were kept for further purification by ultracentrifugation. The 
media has been analysed in a group of seven days, and then results were 
compared between different groups.   
The supernatant was collected and exosomes were separated by 
centrifugation at 110,000 × g for 2 hours at 4 °C using a Sorvall WX100 
Ultra Series ultracentrifuge (Thermo Scientific, Milan, Italy). The exosome 
pellet was collected, washed once with PBS and then resuspended in 100 
µl of PBS containing proteases inhibitors. Besides, the pellet was also 
resuspendend in RIPA buffer, supplemented with proteases inhibitors, in 
order to obtain protein specimens from exosome suspension. Proteins in 
exosomal preparations were quantified by the Quant-iT™ protein assay kit 
(Invitrogen Molecular Probes, Italy), using the Qubit fluorimeter according 
to the manufacturer's instructions (the kit is accurate for protein 
concentrations ranging from 12.5 µg/ml to 5 mg/ml). 
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2.7.1 Exosomes assessment: NanoSight Technology.  
The Nanosight (NS 300, Amesebury, UK) system, was used in this work 
under the guidance of a technicians and it has allowed to assessing the 
size profile of extracellular vesicles in ultra-centrifuged pellets. This 
platform is based on nanoparticle tracking analysis (NTA), a method that 
lead to visualization and analysis of each single nanoparticle suspended in 
liquid in real-time, by direct observation of diffusion. NTA connects the rate 
of Brownian motion to particle size, and the vesicles are visualized by light 
scattering using a light microscope. 
The conditioned media from 16-HBE and H292 cells, both treated and 
untreated with CSE, were collected and processed as described above 
(see the section 2.7). The resultant pellets were pooled between the same 
conditions, washed with PBS and stored at -80°C until use.  
The samples were diluted and a finely focused laser beam was introduced 
to each sample. The particles contained in the sample were visualized by 
virtue of the light scattered by the particles when they were illuminated by 
light laser. Particles scattering from laser beam were captured using a 
scientific digital camera and the motion of each particle was tracked from 
frame to frame, recording video frames of 60 seconds. This rate of particle 
movement is related to a sphere equivalent hydrodynamic radius as 
calculated through the Stokes-Einstein equation. 
  
2.7.2 Exosomes assessment: Transmission Electron 
Microscopy (TEM). 
The purified exosome-like vesicles were resuspended in PBS and fixed 
with Karnovsky’s fixative (2.5% paraformaldehyde, 0.5% glutaraldehyde in  
0.1M PBS pH 7.2) and then embedded in 2% low-gelling agarose (type 
VII; Sigma). The agarose-embedded samples were post-fixed in 1% OsO4 
for 2 hours, dehydrated in a graded ethanol series, passed through 
propylene oxide and infiltrated with  epoxy resin (Epon812, Electron 
Microscopy Science, Hatfield, PA, USA) in propylene oxide (1:3, 1:2, and 
1:1 for 30 minutes with agitation at room temperature, respectively), and 
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finally embedded in Epon812 with DMP30. Samples embedded in resin 
were polymerized at 60°C for 48 hours 119. 
Ultrathin sections (60 nm) were cut with an ultra-microtome (Ultracut E, 
Reichert-Jung, Depew, NY, USA) and were finally stained with 2% uranyl 
acetate prior to viewing by transmission EM (TEM) using a Jeol JEM1010 
microscope at 60 kV. Images were acquired with a digital camera 
MegaView III with Olympus Image Analysis Software (Secciòn de 
Microscopìa Electrònica, SCSIE, University of Valencia). 
 
2.7.3 Exosomes assessment: Alix and Hsp70 detection.  
The presence of exosomes was confirmed by detection of exosomal 
marker, such as  Alix and Hsp70, using Western Blotting as described 
above. 
 
3. Experiments ex vivo. 
3.1 Biopsy specimens.  
We obtained bronchial biopsies from 9 subjects (Table 5). 
 
 Status Smoker No smoker 
Number 4 5 
Male gender (%) 67% 33% 
Mean age (range) 71±10 48±17 
Table 5. 
Characteristics of subjects studied by bronchial biopsy analysis. 
 
3.1.1 Fiberoptic bronchoscopy, collection and processing of 
bronchial biopsies. 
Subjects were at the bronchoscopy suite at 8.30 AM after having fasted 
from midnight and were pre-treated with atropine (0.6 mg IV) and 
midazolam (5–10 mg IV). Oxygen (3 l/minutes) was administered via nasal 
prongs throughout the procedure and oxygen saturation was monitored by 
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a digital oximeter. (Olympus BF10 Key-Med, Southend, UK) which was 
passed through the nasal passages into the trachea. Further lidocaine 
(2%) was sprayed into the lower airways, and four bronchial biopsy 
specimens were taken from segmental and sub-segmental airways of the 
right lower and upper lobes using size 19 cupped forceps 
 
3.2 Bronchial Three-dimensional (3D) Outgrowth Model.  
The three-dimensional culturing of bronchial biopsy cells was used to 
closely mimic the in vivo bronchial microenvironment, unlike the traditional 
two-dimensional monolayer culture.  
To achieve the bronchial out-growth cultures, the necessary equipment 
are Tranwells with 0.4 μm pore size, Trasparent PET track-etched 
membrane (Falcon, 353095); 24 well plates (Falcon, 353504); BD 
Matrigel™ Basement Membrane Matrix (BD, 356234) and BEGM/DMEM 
mix medium (containing BPE, Bovine Pituitary Extract, 2.0 ml; 
Hydrocortisone, 0.5 ml; hEGF, 0.5 ml; Epinephrine, 0.5 ml; Transferrin, 0.5 
ml; Insulin, 0.5 ml; Retinoic Acid, 0.5 ml; Triiodothyronine, 0.5 ml; GA, 
Gentamycin/Amphotericin, 0.5 ml). 
Biopsies, few minutes after taking, were washed three times with PBS and 
cut into 0.5 mm3 pieces using a sterile scalpel. Each piece was placed in 
the middle of transwell and embedded in 60 µl of BD Matrigel™. The 
Matrigel is a solubilized basement membrane preparation extracted from 
the Engelbreth-Holm-Swarm (EHS) mouse sarcoma, including laminin (a 
major component), collagen IV, heparan sulfate proteoglycans and also 
contains TGF-beta, EGF, IGF, FGF and tissue plasminogen activator. 
Matrigel provide specialized microenvironments that mimic native tissues 
and enable cells to grow and differentiate into specific cell types. The 
Transwells were placed in 24 well culture plates and these were then kept 
at 37°C for 5 minutes to facilitate MatrigelTM jellification. 330 μl of growth 
medium mix was added to each well. This medium was constituted of 
BEGM/DMEM (1:1) (Bronchial Epithelium Growth Medium/ Dulbecco’s 
modified Minimum Essential Medium) with 10% fetal bovine serum (FBS). 
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The outgrowths were cultured at 37°C in 5% CO2 atmosphere and the 
medium has been changed every 48 hours.  
Bronchial out-growths were routinely observed by inverted phase contrast 
light microscopy (LEICA DM-IRB, Leica Microsystems Srl, Milan, Italy), 
and photographed to record the growth. 
 
3.3 Treatments. 
The conditioned medium to treat bronchial 3D outgrowth was obtained 
similarly to the CSE used for monolayer cultures. The smoke from one 
commercial cigarette, filters removed, was bubbles through 25 ml of BEBM 
(Bronchial Epithelium Basal Medium) medium serum-free (see the section 
2.2). The filtered and pH adjusted CSE, called 100% was mix to BEGM in 
order to achieve the concentration range of CSE from 10 to 30%. This 
suspension was applied to the bronchial 3D outgrowth for different times 
(Fig. 7).   
 
 
Figure 7. 
Schematic overview of 3D outgrowth seeding and treatments (adapted from 
Schamberger at al 2015 
120
). 
 
3.4 Teer measurement. 
Transepithelial electrical resistance (TEER) was measured on 10th day to 
ensure the formation and integrity of tight junctions between cells in the 
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epithelium using an EVOM meter (World Precision Instruments, FL). 
Before measurement, the apical layer of the cultures was washed with 
PBS and then 15 µl of PBS was added to the apical and basolateral side 
in order to equilibrate the cultures (the incubation time was 15 minutes). 
Measurements were performed three times per well and a mean 
resistance value was calculated. Then, values were corrected for the blank 
resistance (membrane with no cells) and the surface area. 
 
3.5 Determination of DNA damage: Tunel assay. 
The presence of apoptotic cells, after CSE treatment, was detected 
through the study of DNA fragmentation using TUNEL assay, that 
preferentially labels DNA strand breaks, generated during apoptosis. The 
Fluorescein In situ cell death detection kit (Roche Applied Science, 
Indianapolis, IN) was used. 
Both 3D outgrowths treated with 30% CSE for 7 days and untreated 3D 
outgrowths were washed with PBS twice and fixed with ice-cold methanol 
(30%, 10 minutes; 70%, 10 minutes and 100%, 10 minutes) at 4°C inside 
their plastic supports. After the cultures were fixed, outgrowths were left to 
dry in a laminar flow cabinet for 30 minutes and then removed from plastic 
supports. At this point outgrowths were embedded in Tissue Tek II OCT 
and 8 mm thick cryostat sections were cut and processed for Tunel 
analysis.  
The sections were rehydrated accordingly with PBS and incubated with 
proteinase K, to avoid false-positive results, at 24°C for 30 minutes, then 
at 24°C for 8 minutes with a permeabilization solution (0.1% Triton X-100, 
0.1% sodium citrate). Indeed, the slides were incubated in the Tunel 
reaction mixture, including Label solution and enzyme solution, in 
humidified atmosphere for 60 minutes at 37°C in the dark. Positive 
controls, using DNase I recombinant (20 U/ml) and negative controls 
(without terminal transferase) were included in each experiment. Therefore 
the sections were mounted using the Vectashield Antifade mounting 
medium (Vector) and examined under CSLM (Confocal Laser Scanning  
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Microscopy), Leica Confocal Microscopy (TCS SP8, Leica Microsystems, 
Milan, Italy). TUNEL-positive cells were enumerated by counting the 
labelled cells in eight randomly selected microscopic fields obtained from 
each specimen at 40× magnification. Therefore, the percentage of 
TUNEL-positive cells was calculated and averaged. 
 
3.6 Study of Hsp60 levels in 3D bronchial outgrowths treated with 
CSE. 
To assess the Hsp60 levels in bronchial outgrowths after treatment with 
different concentration of CSE for various times, the expression and 
proteins levels of this chaperon were evaluated. 
 
3.6.1 RNA Isolation, Retro Transcriptional (RT PCR) and Real 
Time PCR (qPCR). 
The bronchial outgrowths were stimulated by CSE (0, 10 and 30%) for 10 
days and another group with CSE (10 and 30%) for 10 days and, than 
smoke-stimulated medium was removed and replaced with fresh medium 
for 10 days, in order to obtain a recovery. After that, the cells were 
removed from plastic supports and total cellular RNA was extracted using 
TRI Reagent®. PET membrane was taken out from resulting mixture and 
RT PCR was performed following the procedure described above (see the 
section 2.4).  
The qPCR technique was performed for outgrowths treated by CSE for 21 
days, using 20 ng of RNA. RNA was retro-transcribed using the ImProm-II 
Reverse Transcriptase Kit (Promega Corporation) in order to obtain cDNA, 
which was amplified using the GoTaq qPCR Master Mix (Promega 
Corporation, USA). The reaction mix was prepared with cDNA template, 
upstream and downstream PCR primers and GoTaq® qPCR Master Mix, 
2X. The cycling program was carried out with the Rotor Gene Q, Qiagen 
(Qiagen, Milan, Italy), using the following steps: Hot-Start Activation, 1 
cycle at 95°C for 2 minutes; denaturation, 40 cycles at 95°C for 15 
seconds; annealing/extension at 60°C for 60 seconds; dissociation, 1 
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cycle at 60–95°C. The mRNA levels were normalised to the levels 
obtained for hypoxanthine phosphoribosyltransferase 1 (HPRT1) and for 
beta-glucuronidase (GUSB). Changes in the transcript level were 
calculated using the 2-∆∆Ct method 121. The cDNA was amplified using 
the primers indicated in Table 6. 
 
 
Primer Forward Reverse 
Homo HSPD1 
var1 
5’-
GAGTAGAGGCGGAGGGAG-3’ 
5’-
AGTGAGATGAGGAGCCAGTA-
3’ 
Homo GAPDH 5’-TCCCTCCAAAATCAAGTG-3’ 5’-GGCAGAGATGATGACCC-3’ 
Homo GUSB 
5’-
CGAGTATGGAGCAGAAACGA-
3’ 
5’-
TTTATTCCCCAGCATCCTCG-
3’ 
Homo HPRT1 
5’-
GAGTCCTATTGACATCGCCA-
3’ 
5’-
CGCCCAAAGGGAACTGATAG-
3’ 
Homo β-actin 
5’-CAC CTT CAC CGT TCC 
AGT TT-3’ 
5’-AGG TAC TCC GTG TGG 
ATC GG-3’ 
Table 6. 
Forward and reverse primers used for the polymerase chain reaction. 
 
3.6.2 Protein isolation and Western Blotting analysis. 
The Hsp60 levels in 3D bronchial outgrowths were analyzed at different 
time points of CSE treatment: 2, 7 and 21 days. Samples were removed 
from their plastic supports and 500 µl of RIPA buffer was used to lyse 
cells. PET membrane was take out from resulting suspension and lysis 
method and western blotting were performed as described above (see the 
section 2.5).   
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3.7  Bronchial 3D outgrowths characterization by 
immunofluorescence and morphological assessment of CSE effect.  
Immunofluorescence analysis was carried out to evaluate the distribution 
of epithelial markers and Hsp60. 
3D cultures were grown up to reach the appropriate growth and then 
washed with PBS and fixed with ice-cold methanol (30%, 10 minutes; 
70%, 10 minutes and 100%, 10 minutes) at 4°C. The fixed outgrowths 
were left to dry in a laminar flow cabinet for 30 minutes and then they were 
removed from plastic supports. At this point outgrowths were embedded in 
Tissue Tek II OCT and 8 mm thick cryostat sections were cut and 
processed for immunofluorescence analysis. 
The specimens were washed with PBS, pH 7.4, and then were incubated 
with the unmasking solution (10mM trisodium citrate, 0.05% Tween 20) for 
10 minutes at 23 °C. Therefore, the sections were incubated with the 
blocking solution (3% bovine serum albumin in PBS) for 30 minutes at 23 
°C and with the pertinent primary antibody overnight at 4 °C. 
Subsequently, the sections were incubated with the second primary 
antibody overnight at 4 °C (anti-α-Actinin antibody, diluted 1:300; anti-
TJP1 antibody, diluted 1:200; anti Hsp60 antibody; all purchased from 
Sigma-Aldrich, Milan, Italy). After washing twice with PBS, all slides were 
incubated with fluorescent secondary antibodies (rabbit IgG antibody 
conjugated with Texas Red, Gene Tex Inc, dilution 1:200; FITC-
conjugated donkey anti-goat secondary antibody, Gene Tex Inc., 
dilution1:200) for 1hour each at 23°C. The nuclei were counterstained with 
Hoechst (Sigma-Aldrich, Inc, Milan, Italy) for 15 minutes at 23 °C. Finally, 
all slides were mounted by cover slips using a drop of Vectashield 
(Vector). Images were captured using inverted laser scanning 
fluorescence confocal microscope (Leica Confocal Microscope, TCS SP8; 
Leica Microsystems) equipped with acquisition and analyses software. 
FITC and TRITC filters were used. 
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3.7.1 Detection of Hsp60 in conditioned medium: ELISA. 
Elisa was performed using a commercial Hsp60 (human) enzyme immuno-
assay (EIA) kit (ADI EKS 600 ELISA kit from Enzo Life Sciences, Inc., 
Farmingdale, NY, USA). It is quantitative sandwich immunoassay, in which 
a mouse monoclonal antibody is pre-coated on the wells of plate. Hsp60, 
present in the sample, was captured by the immobilized antibody and 
detected  by an Hsp60 specific, goat polyclonal antibody.  
In addition, we performed a quantitative comparison of Hsp60 levels in 
conditioned medium of 3D bronchial outgrowth treated with CSE (30%) for 
0, 7, 14 and 21 days. The assay was performed also to test Hsp60 levels 
in plasma collected from patients with mild/ severe COPD (age 68±14 
years) and from healthy (age 60±10 years) volunteers as controls. 
Whole blood sample from each subject were collected in EDTA-treated 
tubes. After a centrifugation at 2,000×g for 30 minutes, plasma was 
collected, aliquoted, and stored at −20 °C until use. The Hsp60 standard 
was diluted in sample diluent to generate a standard curve with six points, 
ranging from 3.125 to 100 ng/ml, and sample diluent alone was used as 0 
(zero) standard.  
First, 100 μl of prepared standards and undiluted plasma was added in 
duplicate to wells of the immunoassay plate precoated with mouse 
monoclonal antibody specific for Hsp60 and incubated at 23 °C for 1 h. 
The primary and the secondary antibodies were diluted according to the 
manufacturer's instructions. Therefore, 100 μl of diluted anti-Hsp60 goat 
polyclonal antibody was added to each well and incubated at 23 °C for 1 h. 
After washing, 100 μl of diluted horse radish peroxidase-conjugate anti-
goat IgG was added to the plate and incubated at 23 °C for 30 minutes 
followed by 100 μl of 3,3′,5,5′- tetramethylbenzidine substrate for 15 
minutes in the dark. Finally, 100 μl of Stop Solution was added, and 
absorbance was measured at 450 nm in a microplate photometric reader 
(Microplate reader, Euroclone, Milan, Italy). Sample concentration was 
calculated by interpolating the sample concentrations in the standard 
curve. The sensitivity of the human Hsp60, EIA kit was determined to be 
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3.125 ng/ml. Human Hsp60 EIA kit is specific for Hsp60 and the Hsp60 
ELISA has been certified for the detection of human Hsp60. 
 
3.7.2 Detection of cytokines in conditioned medium: Multiplex 
cytokine determination assay. 
To evaluate the bioactive molecules release, such as cytokine, from 
outgrowths treated by the smoke extract, a cytokine profile assay was 
performed. Bio-Plex Pro™ Assay, human cytokine multiplex kit was 
purchased from Bio-Rad Laboratories (Bio-Rad, CA, USA) and was used 
following the manufacturer’s instructions.  
The 3D bronchial outgrowths were treated by CSE (30%) for 0, 7, 14 and 
21 days and culture supernatants were retrieved every two days and 
grouped in 7, 14 and 21 days treatment groups. Media were conserved a -
80°C until use. 
The supernatants were analysed simultaneously for 17 cytokines, 
including IL-1b, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70, Il-13, IL-
17, TNF-α, IFN-γ, TNF-β, MCP-1, MIP-1, G-CSF and GM-CSF with a Bio-
Plex machine, which employed a bead-based sandwich immunoassay.  
Plates were incubated with diluted beads (1X) and washed two times. 
Cytokine standards, controls and unknown samples were added (50 μl 
total volumes) to 96 well plates in duplicates and incubated with detection 
antibody-immobilised micro beads. Indeed, for the detection of multiple 
cytokines, a monoclonal antibody specific for each cytokine was coupled 
to a particular set of beads and Streptavidin-Phycoerythrin reagent (SA-
PE, 1X), with known internal fluorescence, was used. The assay was 
analysed by the Bio-Plex manager software (version 4.0) and a standard 
curve was used to relate and calculate the concentration of each cytokine. 
The sensitivity of this method was less than 10 pg/ml and the assay could 
accurately detect cytokines in the range of 1-32,000 pg/ml.  
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4. Assessment of circulating levels of Hsp60 in COPD 
patients and exosomes-PBMC co-cultures. 
4.1 Assessment of circulating levels of Hsp60 in COPD patients: 
ELISA. 
3 ml of Ficoll-Paque media (Ficoll® Paque Plus GE Healthcare, Milan, 
Italy) were added to the anticoagulant-treated blood samples from COPD 
patients and healthy control volunteers (Table 7) and centrifuged at 300 x 
g, for 30 minutes at 23°C. The upper layer containing plasma was drawn 
off, while the mononuclear cell layer was transferred to a sterile centrifuge 
tubes for later use. 
The plasma samples were diluted to perform ELISA using a commercial 
Hsp60 (human) enzyme immuno-assay (EIA) kit, as described above (see 
the section 3.7.1); to evaluate the levels of the circulating Hsp60 in COPD 
patients compared with normal controls. 
 
Status COPD Healthy control 
Number 5 7 
Mean age (range) 68±14 60±10 
Table 7. 
Characteristics of subjects studied for  Assessment of circulating levels of Hsp60. 
 
4.2 Establishing of exosomes-(PBMC) peripheral blood mononuclear 
cells co-cultures. 
PBMCs were cultured in RPMI 1640 with 10% heat-inactivated fetal calf 
serum (FCS) and supplemented with 2 mM glutamine, 50 U/ml penicillin, 
and 50 mg/ streptomycin; with a density of 2 x 106 cells. 
Cell were treated for 24 hours with exosomes isolated from conditioned 
medium of outgrowths (0 and 30% of CSE at 21 days of treatment). The 
amount of exosomes used for the treatment was the volume 
corresponding to 50 μg of proteins (as described by Jong-Kuen and 
colleagues, 2013 
122
). Cells were also treated with 10 μg/ml of 
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recombinant Hsp60 (V13-31176, Vinci-Biochem srl, Firenze, Italy). To 
control for possible lipopolysaccharide contamination, antibiotics were 
used. 
Therefore, the supernatants were collected and centrifuged at 300 x g in 
order to remove cells. The level of cytokines released was tested through 
Bio-Plex machine, as described above (see the section 3.7.2).  
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Results 
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1. In vivo analysis of Hsp10 and Hsp60 levels and cellular 
localization. 
Firstly, the levels of Hsp10 and Hsp60 in epithelium and lamina propria of 
bronchial mucosa of non-smoking and smoking subjects with normal lung 
function were quantified, by immunohistochemistry. The aim was to 
evaluate the localization of these proteins and to determine whether an 
increase association with smoking was present. Neither Hsp10 nor Hsp60 
levels showed significant quantitative changes in epithelium or in lamina 
propria of the bronchial mucosa of smokers compared with non-smokers 
(Figure 8 A). Both molecules showed a cytoplasmic positivity, often with a 
granular pattern resembling a mitochondrial positivity (figure 8 B). Hsp10 
was positive in both groups of subjects, smokers and non-smokers, and in 
both epithelial and lamina propria cells, while Hsp60 positivity was clearly 
in the cytosol. 
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Figure 8.  
Immunohistochemical detection of Hsp10 and Hsp60 in human bronchial mucosa. (A) 
The levels of Hsp10 in epithelium (Ep) and in lamina propria (LP) were similar in non-
smokers compared with smokers. Hsp60 was detected only in epithelial cells and its 
levels were also similar in non-smokers and smokers. Statistical analyses showed that all 
of the variations were not significant with p-values ranging between p=0.1 and 0.4. (B) 
Representative immunohistochemical images. Hsp10 is present in epithelium and lamina 
propria cells of non-smokers and smokers, whereas Hsp60 is present only in epithelial 
cells. Arrowheads, epithelial positivity; arrows, lamina propria positivity. Scale bars, 50 
µm. 
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2. Monolayer in vitro model. Reproducing smoke-induced 
oxidative stress and evaluation of Hsp60 levels and 
localization. 
2.1 16 HBE cells exposure to CSE and cell viability evaluation. 
To assess the cytotoxic effect of CSE on 16 HBE cells, cell viability was 
measured by MTT assay. Cells were treated with increasing 
concentrations (within the range of 0-100%) of CSE for 24 and 48 hours. 
The suspension had a dose- and time-dependent cytotoxic effect (Figure 9 
A, A1 and B1). After 24 hours of treatment, CSE reduced cell viability by 
70% with 25% of CSE (Figure R. 2A and R. 2A1). The effect was even 
more pronounced after 48 hours of treatment with 25% CSE when 80% of 
cells were dead with 25% of CSE (Figure 9 B). These effects were 
statistically significant when compared to untreated cells (p-value less than 
0.05). The doses which caused the death of 50% of the cells (IC50) were 
estimated to be 15% and 10% after 24 and 48 hours of CSE treatment, 
respectively. Using this method the viability of the cells that remain 
attached, regardless of the detached cells, were taken into account. 
Floating cells dead or were dying and this process was proportional to the 
CSE doses, indeed it did not invalidate MTT results.   
 
 
Figure 9. 
16 HBE cells (8x10
3
/well) were treated with increasing CSE doses for 24 (A) and 48 (B) 
hours, and then cell viability was assessed using the MTT test and expressed as the 
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percentage of the viable cells compared with untreated. A dose-dependent decrease of 
16-HBE cell viability was observed. The IC50 values after 24 and 48 hours were 15 and 
10%, respectively. Values represent the means of three independent experiments ± S.D. 
(*different from control p-value<0.001 and § different from control p-value<0.05).  
 
2.2 Analysis of Hsp60 and Hsp10 mRNAs expression. RT-PCR. 
The study of Hsp60 was the main objective of this study as Hsp60 is an 
important chaperonin involved in the protection of cells from oxidative 
stress. For that reason, in this work, we studied the level of this protein as 
well as of Hsp10, which is its co-chaperone.  
At transcriptional level, the quantification of Hsp60 mRNA levels in 16 HBE 
cells by RT-PCR revealed that CSE treatment (10, 5 and 2.5%)  did not 
have any significant effect on Hsp60 expression (Figure 10 A and B, upper 
panel). Likewise, we did not find any significant differences in Hsp10 
mRNA levels between treated and non-treated cells (Figure 10 A and B, 
lower panel). 
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Figure 10. 
(A) RT-PCR analysis of mRNA Hsp60 and Hsp10 levels and (B) respective densitometry 
of corresponding bands. Hsp60 mRNA was not significantly different after treatment with 
10% CSE when compared with the untreated cells, and also the Hsp10 mRNA did not 
change significantly. Values represent the mean of three independent experiments ± S.D. 
 
2.3 Hsp60 protein analysis: Immunocytochemistry (ICC). 
In accordance with the RT-PCR data, neither Hsp60 nor Hsp10 
expression were changed when cells were tested in all conditions (0, 2.5, 
5 and 10% of CSE) and Hsp60 and Hsp10 levels were assessed by 
immunocytochemistry. Hsp60 positivity was localized in cytosol and 
mitochondria (Fig. 12 A), while Hsp10 was present normally in cytosol 
(Fig. 12 B).  
For further in vitro studies we decided to be focused on Hsp60, because 
Hsp10 was object of another thesis from our department 112, were the 
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localization and changes of Hsp10 in lung cells in response to CS was 
studied. 
 
 
Figure 11. 
Immunocytochemical analisys of Hsp60 (A) and Hsp10 (B) expression, after 24 hours of 
the CSE treatment (representative images of three experiments are presented here). Not 
significant changes were observed in both Hsp60 and Hsp10 expression. Magnification 
40X. 
 
2.4 Hsp60 protein analysis: Western Blotting (WB).  
To determine whether CSE treatment (the same percentage of CSE to 
treat cells for different time points, as described above) induces changes 
in Hsp60 protein levels in 16 HBE cells, the western blotting analysis was 
performed. Western blotting analyses were performed at different times, 
after 4, 8, 16, 24 and 48 hours of the treatment in order to study if possible 
immediate or tardive variations of this protein exist (Fig. 11 A). The results 
do not show significant changes in the levels of Hsp60 in 16-HBE after 
treatment with 2.5, 5 and 10% of CSE compared to untreated (UT) cells 
(Fig. 11 B). 
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Figure 12. 
(A) Western blotting of Hsp60 after 4, 8, 16, 24 and 48 hours of CSE treatment in 16 HBE 
cells; (B) representative densitometry of protein bands (24 hours). Arbitrary units (A.U.) of 
band intensities were normalized to those of the control in each series of experiments. 
Hsp60 protein levels did not change significantly after treatment when compared to the 
untreated cells.  
 
2.5 Hsp60 cell distribution assessment: Immunofluorescence 
analysis (IF). 
Double immunofluorescence tests were performed to assess the co-
localization of Hsp60 and EGFR (a plasma membrane marker) in 16 HBE 
cells treated with smoke extract, considering the hypothesis that Hsp60 
may be secreted by the cells following oxidative stress. The representative 
data (10% of CSE) shows only a single staining, indicating that Hsp60 was 
not present in the membrane (Fig. 13 A, B, C and D). 
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Figure 13. 
Double immunofluorescence analysis of Hsp60 cellular distribution and EGF-R in CSE-
treated 16 HBE cells showed Hsp60 positivity both in mitochondria and cytosol. (A), (B), 
(C) and (D) representative image of 16 HBE cells treated with 2.5% CSE. (A) EGF-R was 
detected by TRICT conjugated antibody, (B) Hsp60 by a FITC conjugated antibody and 
(C) nuclei were stained by Hoechst 33342 and fluorescent cells were visualized by a 
confocal Leica microscope with fluorescent filters for TRICT, FITC and HOECHST 
respectively. Distribution of the chaperonin is shown by the merge (D) of Hsp60 and 
nuclei staining (Bar=30µM). 
 
2.6 Hsp60 protein expression and localization in NCI-H292 cells: 
Western Blotting (WB) and Electron Transmission (TEM)-
ImmunoGold. 
This first set of in vitro study results suggests, that the Hsp60 levels were 
not changed in 16 HBE cells, when exposed to CSE. This could partly be 
explained because smoke exposure induces oxidative stress which is 
easily overlooked by the homeostasis maintenance cell systems of 
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immortalized cells such as 16 HBE or more likely, because the mechanism 
of immortalization used for the 16-HBE has fallen into genomic portions 
that regulate the response of these cells to oxidative stress, preventing 
them to respond properly to the presence of CS.  
For this reason, it was investigated whether CSE had a more relevant 
effect in tumoral cells (NCI-H292, mucoepidermoid carcinoma cells) which 
are a routine model used in assessment of smoking effects. After testing 
increasing concentrations of CSE on H292 cells, in order to determine the 
IC50, using MTT (Fig. 14 A), The Hsp60 levels in H292 cells treated with 
2.5, 5 an 10% of CSE for 24 hours, were detected (Fig. 14 B and B1), by 
western blotting analysis. It was found that Hsp60 levels were increased in 
dose-dependent way, unlike 16 HBE (10% of CSE was significantly 
different compared to control, p<0.05).  
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Figure 14. 
(A) Graph of MTT assay to determine the percentage of CSE in the treatment of H292 
cells. The IC50 value after 24 hours was 20% and then, we have chosen sub-lethal doses 
(2.5, 5 and 10% of CSE). Values represent the mean of three independent experiments ± 
S.D. (*different from control p <0.001). (B) Western blotting of Hsp60 after 24 hours of 
CSE treatment of H292 cells. In figure (B1) representative densitometry of protein bands. 
Arbitrary units (A.U.) of band intensities were normalized to those of the control in each 
series of experiments. Hsp60 protein levels were increased significantly after treatment 
when compared to the untreated cells (10% of CSE was different from control *p <0.05). 
 
Various studies have shown that Hsp60 levels could change in 
pathological conditions or in inflammatory states 76,123. It has been 
demonstrated that Hsp60 can translocate in different cell localizations and 
come out of the cell, frequently inside extracellular vesicles, such as 
exosomes. A previous study from Campanella and colleagues 96 proved 
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the presence of Hsp60 in the plasma membrane of the tumor cells (H292), 
demonstrated by Transmission Electron Microscopy (TEM)-immunogold. 
Hsp60 was localized not only in the cytosol but also in plasma membrane 
as well as close to the plasma membrane, suggesting an active movement 
of the chaperonin in this area, possibly toward, and also away from the cell 
(Fig. 15). For these reasons, we investigated a possible mechanism of 
secretion, through extracellular vesicles, to verify the possible presence of 
Hsp60 in them (see below). 
 
 
Figure 15. 
Modified from Campanella and colleagues, 2012 
96
. Transmission electron microscopy-
Immunogold demonstration of Hsp60 (black dots) in H292 cells. Arrows indicate the 
Hsp60 molecules that are close or onto the cell membrane. The insert shows the typical 
pattern of Hsp60 in a mitochondrion, which serves as a positive internal control. Bar: 100 
nm. 
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2.7 Exosomes isolated from 16 HBE and H292 cells showed typical 
characteristics.  
Previous observation has shown that Hsp60 is released in the extracellular 
microenvironment via the exosomes pathway and therefore the 
experiments below were aimed to investigate whether cigarettes smoke 
affects the exosomal pathway on tumor cells.  
We obtained Extracellular Vesicles (EVs) from 16-HBE and H292 cells, 
using single step ultracentrifugation. Therefore, we analysed our exosome 
preparations by TEM, and found that the size and the morphology of the 
obtained EVs were those of typical exosomes (Fig. 16 A1 and A2; 
representative TEM images). These results show that exosomal 
preparation from cell treated with CSE (10%) had more vesicles than 
preparation from untreated cells. These data are obtained by the 
“Analyzing particles” of ImageJ software. Our exosomes preparations were 
analyzed by Nanosight, Nanotracking particle analysis (NTA), that 
measures the size of each particle and their number, by direct observation 
of scattered light and the particle motion (Fig. 16 B). We found that our 
vesicle population consisted 4.05x108 vesicles/ml, with size distribution 
mean of 100 nm (S.D. ±67) (Fig. 16 C). 
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Figure 16. 
16 HBE and H292 cells release extracellular vesicles, like exosomes, more concentrated 
when treated with 10% of CSE than the control. (A1) and (A2) vesicles compatible with 
typical exosomes, demonstrated by TEM. An illustrative result for exosomes purified from  
(A1) control H292 cells and (A2) H292 cells treated with 10% CSE. (bar=200 nm). The 
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arrow shows MVE (Multi Vescicular Endosomes) with ongoing inward budding of the 
limiting membrane. (B) Nanotracking particle analysis graph of vesicles number and size. 
Size vesicles distribution: mean 100 nm±67. Total Concentration: 19.17 particles/frame, 
corresponding to 4.05x10
8
 particles/ml. (C) Graph of number and size distribution of 
exosomes isolated from untreated cells (blue points) and cells treated with 10% of CSE 
(red point) and observed by TEM.  
 
2.8 Hsp60 is present in exosomes from H292 cells treated with CSE. 
In exosomes from 16-HBE it was not possible to find Hsp60, as expected, 
considering that it was demonstrated that this protein was not present in 
membrane of these cells after CSE treatment (Fig. 17 A, upper panel). In 
basal and conditioned medium, Hsp60 was not detected in exosomes, 
while, it was detected in the exosomes from H292 cell and a significant 
increase in Hsp60 levels was observed after CSE treatment (10%) (Fig. 17 
A, second panel). Western blotting showed that our exosome preparations 
expressed typical exosome markers, such as Alix and Hsp70 (Fig. 17 A, 
middle and bottom panel). 
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Figure 17. 
In (A) Representative western blotting of exosomal Hsp60 after 24 hours of CSE 
treatment of 16 HBE (upper panel) and H292 (second panel). In (A) third and fourth 
panel, respectively Alix and Hsp70 western blots. In (B) densitometry of protein bands of 
Hsp60 obtained from H292 exosomes (10% vs UT * p<0.05), for Alix (B, middle panel) 
and Hsp70 (B, bottom panel). 
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3. Optimization of a three-dimensional ex vivo model 
mimicking COPD and evaluation of  CS exposure effect and 
inflammatory mechanisms.  
3.1 3D outgrowth cultures: growth monitoring and macroscopic 
effects of CSE. 
After the seeding, the bronchial biopsy was routinely observed and 
photographed in order to monitor the growth and cells morphology (Fig. 
18).  
During the first days of culture, the cells started to come out of the biopsy 
(Fig. 18 A and B). Those were mainly fibroblasts, which reconstructed a 
network. Hereinafter also appeared epithelial cells, which are placed 
apically to the fibroblasts. After about 10-15 days, the outgrowth recreated 
the typical morphology of the bronchial epithelium and replaced the 
Matrigel® with self-produced extracellular matrix (Fig. 18 C). Futhermore, it 
is possible to see the cilia beating.  
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Figure 18. 
Bronchial 3D-outgrowth culture: different stages of growing. In (A) 2 days, in (B) 5 days 
and in (C) 10 days growing after culturing. Phase contrast photos (LEICA DM-IRB). 
 
With the gradual increase in cell growth and expansion, it is been possible 
to observe an increase of the trans-epithelial resistance (TEER, Trans-
epithelial electrical resistance), due to the establishment of the epithelial 
barrier. TEER was measured by an EVOM meter (Volt meter) (Fig. 19 A).  
When the outgrowths were treated with 30% CSE, TEER was reduced 
(Fig. 19 B), due to the influence of smoke extract on the cell junctions and 
on wall thickness. 
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Figure 19. 
Trans-epithelial electrical resistance (TEER) was measured every 2 days, from day 10
th
 
after the culture placing, to ensure the formation and integrity of tight junctions between 
cells in the epithelium using an EVOM meter (A). In (B) the effect of 10 (●) or 30% (■) 
CSE on ionic permeability of mature EMTU cultures. After the treatment with 10 and 30% 
CSE, the EVOM measurement was performed every 2 days, to monitor the effect of CSE 
in cellular integrity. Grey circles (●) show the electrical resistance of untreated cultures 
(either pre-CSE exposure or without treatment post 28 days).  
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Substantial morphological differences were observed in the outgrowths 
when exposed to CSE (30%) for 21 days, compared with the un-exposed 
control outgrowths.   
CSE reduces the contact between the epithelial cells and fibroblasts, an 
event that has been described in the literature in the early stages of 
COPD. This could compromise the normal intercellular communication of 
the EMTU and could lead to airway wall thickening. In our model it was 
possible to see a remodelling of EMTU toward metaplasia (Fig. 20 B), as 
confirmed by the morphology of the epithelial layer that becomes 
squamous-like (Fig. 20 A and B). 
 
 
Figure 20. 
The phase-contrast microscopy images of 3D outgrowths show the remodelling of 
morphology of epithelial mesenchymal trophic unit (EMTU) after 21 days of treatment with 
30% CSE. (A) untreated; (B) treated 3D outgrowth.   
 
3.2 Assessment of smoke effect on viability of 3D bronchial 
outgrowths: in situ apoptosis assay. 
To determine the effect of cigarette smoke on DNA fragmentation, 
outgrowths were exposed to 30% CSE for 7 days and then TUNEL 
staining was performed (Fig. 21 A). After 7 days of treatment DNA strand 
breaks significantly increased (p<0.001) compared with control (Fig. 21 B). 
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The percentage of DNA damaged cells increased as a function of CSE 
concentration. 
 
 
Figure 21. 
Apoptosis assay. (A) Representative image of TUNEL staining. Percentages of TUNEL 
positive cells were determined by cell  positive counting. (B) Data are expressed as 
means ± SD (* UT vs 30% p < 0.001). 
3.3 Evaluation of Hsp60 mRNA expression and protein levels of in 
bronchial 3D outgrowths exposed to CSE. 
In an effort to improve our knowledge about Hsp60 mRNA expression in 
the 3D bronchial culture model, total RNA was extracted from outgrowths 
and RT-PCR was performed using gene-specific primers. One group of 
outgrowths was treated for 10 days with CSE (10 and 30%), whereas 
another group was treated with CSE (10 and 30%) for 10 days and then 
the medium was replaced with fresh medium for an additional 10 days. 
Interestingly, Hsp60 expression levels were markedly elevated after 30% 
CSE treatment after 10 days, while after 10 days of treatment and 10 days 
of recovery Hsp60 mRNA was significantly reduced compared to controls 
(Fig 22 A and B; p<0.01). This result suggests that CSE could regulate the 
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transcriptional levels of this molecular chaperone in the 3D model, 
differently than the monolayer model.  
 
 
Figure 22. 
(A) RT-PCR analysis of Hsp60 mRNA levels and (B) densitometry of corresponding 
bands. Hsp60 mRNA was significantly higher after treatment with 30% CSE when 
compared with the untreated controls. Values represent the mean of three independent 
experiments. (*Different than UT p<0.01, § different than UT recovery  p<0.05). β-actin 
was used as loading control. 
 
In the subsequent experiments we have chosen different time points of 
treatment, in order to study the real variations in protein levels. 
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It was found that the results of western blotting analysis Hsp60 protein 
level (Fig. 23) were comparable with the expression analysis of Hsp60 
mRNA. The quantity of Hsp60 was higher after 2 days of treatment than in 
control samples (Fig. 23 A1, B1) and lower when outgrowth were treated 
with smoke (10 and 30% of CSE) for 7 and 21 days (Fig. 23 A2, B2 and 
A3, B3). Also after 21 days of the treatment the Hsp60 mRNA levels were 
reduced in the treated rather than in the control cells (Fig. 23 C3). These 
western blotting results are in accordance with the expression analysis 
results and these difference between expression after 7 and 21 days may 
be due to the fact that for brief treatment times might lead to an immediate 
response in which the system increases the levels of this protein, while 
when the treatment is prolonged the system regains its equilibrium.  
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Figure 23. 
Western blotting analysis of Hsp60 levels for 2 (A1), 7 (A2) and 21 (A3) days after the 
treatment with CSE. In B1, B2 and B3 the corresponding densitometry bands. After 2 
days of treatment we observed an increase in Hsp60 protein levels (A1 and B1). 
Conversely, after 7 (A2 and B2) and 21 days (A3 and B3) of treatment Hsp60 was 
reduced in dose dependent mode (p<0.001). In (C3) Real Time PCR analysis of Hsp60 
expression levels after 21 days of treatment with 30% CSE. mRNA levels were 
considerably reduced (Δ UT vs 30% p < 0.001), and confirm the western blotting data. 
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3.4 Bronchial 3D outgrowths characterization and evaluation of CSE 
effects: smoke decreases barrier function and Hsp60 levels in 
epithelium of bronchial 3D outgrowths. 
Samples were stained for anti-α-actinin (Fig. 24 A and B, red) to verify the 
growing and morphology of outgrowth and with Hsp60 (Fig. 24 A and B, 
green) to study the localization of this protein in 3D bronchial model, 
considering its decrease after CSE treatment for long time. α-actinin 
presents typical organization, compatible with his normal localization, 
along cytoskeleton and near membrane. Hsp60 appears normally 
cytoplasmic. 
 
 
Figure 24. 
3D outgrowths were cultured for 44 days, fixed with methanol and triple-stained with 
TRICT, conjugated with anti-α-actinin antibody, with FICH, conjugated with Hsp60 
antibody and with the nuclei probe HOECHST. Cells were analyzed in a Leica laser 
scanning confocal microscope. In (A) and (B) different field of an outgrowth cultured for 
44 days. 
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In an effort to elucidate the mechanism by which the trans-epithelial 
resistance was reduced after treatment with 30% CSE, we investigated 
the expression and localization of the tight junctions, a component of cell-
cell adhesion. Bronchial outgrowths were exposed to 30% of CSE for 21 
days and a double immunofluorescence analysis was performed (Figure 
25 A and B) in order to evaluate the expression of tight junctions and 
Hsp60. The overall molecular composition of tight junctions was reduced 
and modified, appearing discontinuous and fragmented. The 
immunoreactivity of considered protein was always localized in 
correspondence of epithelial cells membranes (Figure 25 B). Furthermore, 
Hsp60 was reduced after treatment, according to western blotting analysis 
(Figure 25 B). 
 
 
Figure 25. 
Double immunofluorescence experiments for tight junction (green) and Hsp60 (red) show 
a CS-induced disruption of bronchial epithelial tight junctions and a more pronounced 
reduction of Hsp60 levels (B) than in the controls (A). 
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3.5 Bronchial 3D outgrowths exposed to smoke release exosomes.  
In order to understand the localization of Hsp60 after CSE treatment, we 
evaluated the its eventual secretion in the extracellular environment, by 
exosomal pathway. Bronchial 3D outgrowths were treated for 7 and 21 
days with 30% CSE and the conditioned medium was changed and 
collected every 2 days. Conditioned media for each group (7 and 21 days) 
were analysed and compared. From these samples exosomes were 
obtained and their protein content was quantified in order to assess the 
exosomal Hsp60 (eHsp60), exosomal Hsp70 (eHsp70) levels and Alix, the 
latter are well known exosomal markers. We did not find Hsp60 and Alix 
levels, as it is shown in Figure 26 A (lower panel). On the other hand, we 
observed an increase in eHsp70 levels in exosomes from 3D outgrowth 
treated for 21 days when compared to the exosomes controls and 
exosomes from 3D cultures treated for 7 days. This may be correlated with 
an increase in dose- and time-dependent exosomes production (Fig. 26 
and B). We suspect that this model produces exosomes but probably they 
are not the main via by which Hsp60 is released.  
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Figure 26. 
In (A) western blotting analysis of exosomal Hsp70 (upper panel) and exosomal Hsp60 
(lower panel) levels after 0, 7 and 21 days of treatment with CSE. In (B) the 
corresponding densitometry bands for eHsp70 levels. eHsp70, an exosomal marker, was 
present at high levels in exosome preparations from supernatant of bronchial 3D 
outgrowth treated with 30% CSE for 21 days. Data were analysed by Repeated measure 
ANOVA test (*p<0.001, UT and 30% after 21 days of treatment vs UT and 30% at 0 
days). A difference between UT and 30% CSE treatment after 21 days was statistically 
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significant (*p<0.05) as well as between 30% 0 days and 30% 7 day and 30% 21 days 
after the treatment (#p<0.001) .  
 
3.6 Bronchial 3D outgrowths release Hsp60 and cytokines. 
To better understand the reason because intracellular levels of Hsp60 
were decreased after CSE treatment, the level of this protein was tested in 
conditioned medium of 3D bronchial outgrowths treated with CSE (30%, 
after 0, 7, 14 and 21 days), by ELISA assay. We observed a dose- and 
time-dependent increase in Hsp60 levels (Fig. 28). 
 
 
Figure 27. 
Effect of  CSE treatment on Hsp60 release from 3D bronchial outgrowth. Samples  were 
incubated with 30% CSE for 7, 14 and 21 days to study the release of Hsp60 by  
sandwich ELISA, in free cell culture supernatants. We found a significant release of 
Hsp60 in supernatant of outgrowth treated for 21 days, compared with the control 
(*p<0.001). 
 
In addition, an important goal of this work was to clarify the involvement of  
Hsp60 in the inflammatory response in COPD. Therefore, the cytokines 
production from 3D model was verified after exposure to smoke. 
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Seventeen cytokines have been assessed by Bio-Plex assays (Bio-Plex® 
MAGPIX™ Multiplex reader), from supernatants collected every two days 
from 3D outgrowth treated with 30% CSE and grouped into groups: 2, 7, 
14 and 21 days after the treatment. A comparison analysis was conducted 
by repeated measurement ANOVA, between different groups. Among all 
cytokines tested, the data for 9 cytokines were statistically significant 
(p<0.05). 
Supernatant level (pg/ml) of IL1β and IL8 were higher in treated group 
after 14 and 21 days than in respective control. Conversely, levels of IL4, 
TNFα, IL12, IL10 and IL13 were lower than in the respective controls 
(p<0.05). However, the differences between treated and control groups for 
IL2 levels were not significant. 
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Figure 28. 
Conditioned medium levels of IL2 , IL4, IL6, TNFα, IL1β, IL 8, IL 12, IL10 and IL13. 
Significant differences between treated and control samples are denoted (*p<0.05), as 
measured by repeated measures ANOVA test. Data are shown as mean ± S.D. (results 
from three experiments). 
 
In order to find a relationship between Hsp60 release and cytokines levels 
released in conditioned medium of 3D outgrowth in response to the CSE 
treatment, a non-parametric correlation analysis was performed. Linear 
regression curves were developed in GraphPad Prism 6.0 (GraphPad 
Software Inc., La Jolla, CA, USA). The linear regression curve shows a 
high degree of positive correlation between Hsp60 and IL8 (r2 Spearman 
coefficient=0.508, p<0.05) and IL1β (r2=0.712, p<0.05). Otherwise, Hsp60 
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is negatively correlated with IL2 (r2=-0.631, p<0.05), IL13 (r2=-0.685, 
p<0.05); IL4 (r2=-0.633, p<0.05), GM-CSF (r2=-0.926, p<0.05) and IL10 
(r2=-0.589, p<0.05). Other cytokines measured did not correlate with 
Hsp60 level (Fig. 29).  
 
 
Figure 29. 
To test the correlation between the extracellular levels of Hsp60 and any of cytokines 
measured in bronchial 3D outgrowth, linear regression analysis was performed. Whereas 
there was a linear positive correlation between Hsp60 levels and those of IL8 and IL1β 
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(A), negative correlation between Hsp60 levels and IL2, IL13, IL4, GM-CSF and IL10 was 
found (B). 
 
4. Assessment of circulating levels of Hsp60 in COPD 
patients and exosomes-PBMC co-cultures. 
4.1 Assessment of circulating levels of Hsp60 in COPD patients: 
ELISA. 
Hsp60 levels in plasma of COPD subjects were ranged between 11.857 
and 22.571 ng/mL (mean, 17.49 ± 1.194). By contrast, in healthy subjects, 
Hsp60 was ranged between 7.571 and 18.143 ng/mL (mean, 12.73 ± SD 
0.8736). The difference between Hsp60 levels in COPD patients versus 
healthy subjects was significant (p<0.05), as shown in Figure 30. 
 
 
Figure 30. 
Hsp60 plasma levels measured by ELISA in COPD patients vs healthy donors. Statistical 
analysis were performed by t-test (*p <0.05). 
 
4.2 Establishing of exosomes-(PBMC) peripheral blood mononuclear 
cells co-cultures. 
The cross-talk in our model of EMTU exposed to smoke and immune 
system cells via the exosomes was mimicked using a co-culture model. In 
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this co-culture model the effects of exosomes released from both CSE-
treated and untreated bronchial 3D outgrowth, and free Hsp60, on 
activation of immune system, based on cytokines releasing was assessed. 
The PBMC cells isolated from COPD patients, were treated for 24 hours 
with exosomes isolated from untreated and treated (30% CSE) 
conditioned medium of outgrowths. Also, 10 μg/ml of recombinant Hsp60 
were used to treat PBMC cells. The levels of 17 cytokines produced by 
these cells and released in the conditioned medium, were assessed using 
Bio-Plex Pro Assay (Table 8).   
 
Cytokine 
Groups of treatment 
Ctrl Exosome 21 
days Ctrl 
Exosome 21 
days 30% CSE 
Recombinant 
Hsp60 
IL 17A 0.0
a
 ±0.0
b
  
(0.0-0.0)
c
 
26.82 ±5.090 
(22.57-31.08)  
21.66 ±6.105 
(15.25-28.07)  
21.12 ±2.816 
(18.76-23.47) 
IL 1β 2.008 ±1.768 
(0.7434-3.273)  
87.26 ±22.12 
(64.05-110.5)*  
42.27 ±3.620 
(38.47-46.07)* 
#
 
49.85 ±26.06 
(28.06-71.63)* 
#
 
IL 2 1.0 ±0.0  
(1.0-1.0) 
18.99 ±6.332 
(13.69-24.28) 
20.36 ±6.607 
(14.83-25.88)  
15.36 ±2.331 
(12.91-17.80) 
IL 4 1.000 ±0.0  
(1.0-1.0)  
10.02 ±2.752 
(5.644-14.40)  
9.374 ±3.167 
(5.442-13.31)  
7.845 ±1.834 
(4.926-10.76) 
IL 5 OOR< OOR< OOR< OOR< 
IL 6 36.37 ±13.20 
(15.37-57.37)  
1015 ±461.0 
(281.6-1749)  
861.5 ±452.3 
(141.9-1581)  
764.2 ±252.5 
(362.5-1166) 
IL 7 11.93 ±1.581 
(10.61-13.25) 
9.643 ±1.196 
(8.643-10.64)
§
 
9.417 ±1.849 
(7.48-11.36)
§
  
16.06 ±2.795 
(14.06-18.06)* 
IL 8 131.7 ±35.29 
(102.2-161.2)  
3342 ±786.6 
(2685-4000)* 
§
  
3526 ±765.1 
(2723-4328)* 
§
   
1759 ±160.4 
(1504-2015)* 
Il 10 3.680 ±0.8974 
(3.038-4.322) 
76.99 ±19.41 
(60.76-93.21)*§  
65.41 ±19.75 
(48.90-81.91)*  
51.69 ±8.196 
(43.09-60.29)* 
IL 12 2.394 ±0.5250 
(1.742-3.046)  
26.33 ±4.074 
(19.84-32.81) 
24.17 ±4.569 
(16.90-31.44) 
19.06 ±2.432 
(15.19-22.93) 
IL 13 OOR < OOR < OOR < OOR < 
G-CSF 0.0 ±0.0  
(0.0-0.0) 
43.16 ±17.78 
(21.08-65.23)  
34.93 ±23.78 
(5.398-64.45)  
40.20 ±32.17 
(0.2488-80.15) 
GM-CSF OOR < OOR < OOR < OOR < 
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INF γ 0.0 ±0.0  
(0.0-0.0) 
161.3 ±49.46 
(99.86-222.7)  
178.9 ±31.35 
(101.1-256.8)  
122.1 ±20.93 
(70.09-174.1) 
MCP-1 36.41 ±12.96 
(25.58-47.24)  
466.3 ±272.4 
(238.6-694.0)  
417.9 ±180.6 
(266.9-568.9)  
365.9 ±213.6 
(213.1-518.8) 
MIP-1β 234.5 ±132.9 
(69.43-399.5) 
16442 ±0.0 
(69.43-399.5)  
5562 ±0.0 
(69.43-399.5)  
3417 ±0.0  
(69.43-399.5) 
TNF α 2.286 ±1.288 
(1.364-3.208)  
55.11 ±11.20 
(45.74-64.47)*   
40.06 ±5.406 
(34.39-45.73)* 
#
 
35.19 ±5.524 
(29.40-40.99)* 
#
 
 
Table 8.  
Cytokines levels measured by Multiplex Assay. Values are expressed in pg/ml. (
a
 mean; 
b 
S.D. (standard deviation); 
c  
95% C.I. (confidence interval) of mean. OOR = Out of Range; 
OOR> = Out of Range Above; OOR< = Out of Range Below. *p<0.05 vs Ctrl; 
#
p <0.05 vs 
Exo 21 days Ctrl; 
§
p <0.05 vs rHSP60). Statistical analyses and differences were tested 
for significance using one-way ANOVA. 
The PBMC cells from COPD patients released greater levels of IL 6, IL 7, 
IL 8 and MIP-1β, then IL 17A, IL2, IL 4, IL 5, IL 10, IL 12, IL 13, C-CSF, 
GM-CSF, INF γ, MCP-1 and TNF α. All cytokines were higher expressed 
in conditioned medium of treated PBMC cells than in the respective 
controls. 
The cytokines distribution, presented in Table 8, shows a significant 
variation between the different groups (Conditioned medium from 
untreated PBMC, conditioned medium from treated PBMC with 3D 
outgrowth 21 days Ctrl, conditioned medium from treated PBMC with 3D 
outgrowth 21 days 30% CSE and conditioned medium from PBMC treated 
with human recombinant Hsp60), in the pro-inflammatory IL 1β, IL 7, IL 8, 
TNF-α and the anti-inflammatory IL 10 levels. 
As summarized in Figure 31 the secretion of IL 1β, TNF-α and IL 10 was 
more induced by exosome 21 days ctrl, than exosome 21 days 30% CSE. 
The secretion of IL 7 was more induced when PBMC cells were stimulated 
with the human recombinant Hsp60 and, conversely, IL 8 was more 
expressed by PBMC cells treated with both exosome 21 days ctrl and 21 
days 30% CSE.  
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Figure 31. 
Cytokines release was measured by BioPlex Pro Assay. Monocytes from COPD patients 
released greater levels of IL 6, IL 7, IL 8 and MIP-1β, then the others tested, relative to 
controls. (*p<0.05 vs Ctrl; 
#
p <0.05 vs Exo 21 days Ctrl; 
§
p <0.05 vs rHSP60). A 
significant variation between the different groups in IL 1β, IL 7, IL 8, TNF-α and IL 10 was 
observed. 
In addition, the positive correlation was observed between Hsp60 free in 
plasma of COPD plasma, tested by ELISA, and cytokines levels released 
from monocytes exposed to human recombinant Hsp60. Also in this case, 
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the linear regression curves were developed by GraphPad Prism 6.0 
statistical program. The linear regression curve shows a high degree of 
positive correlation between Hsp60 and IL1β (r2 =0.8, p <0.05) and IL 7 
(r2=0.7, p <0.05). Any other correlation between cytokines assessed and 
Hsp60 levels have not been found. 
 
 
Figure 32. 
To test the correlation between the levels of Hsp60 in plasma of COPD patients and 
those of cytokines released by PBMC cells stimulated with the human recombinant 
Hsp60, linear regression analysis was performed. A linear positive correlation between 
Hsp60 levels and those of IL 1β and IL 7 was found. The Spearman coefficient (r
2
) was 
0.8 for IL 1β (p <0.05) and 0.7 for IL 7 (p <0.05). 
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Discussion 
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The main risk factor of COPD, a very debilitating immune-mediated 
disease, is cigarette smoke 10. The main pathological hallmarks of COPD 
are inflammation of the peripheral and central airways with small airways 
and vascular remodelling as well as the emphysema, mucus 
overproduction and chronic bronchitis that allow to the destruction of the 
lung parenchyma.  
The prolonged exposure to CS causes numerous effects on the 
respiratory mucosa, at the molecular level and then on the cell function. 
Smoke evokes the inflammatory response by activation of epithelial cells, 
fibroblasts, macrophages, dendritic cells and T-cells, inducing the 
immunomodulatory response and cytokines 124–126, interleukins and 
chemoattractant production. Smoke exposure alters mitochondrial 
structure and function 127, activates mitogens 128 and its role in the 
extracellular matrix remodelling by lung fibroblast 129 and in the 
reprogramming of apical junction architecture in epithelial cells 24, has 
been proved. Increasing evidence shows a predominant role of Hsps in 
smoke response and in COPD pathogenesis 69,71,72.  
It has been established that Hsps are released in the extracellular 
environment, by several cell types and that they have powerful effects. 
Previous studies have indicated a crucial role of Hsp60 in modulating 
immunity and inflammation 
130
.  Frequently, in response to stress, Hsp-
peptide complexes are released from dead or dying cells and they bind to 
the receptors present on antigen-presenting cells, determining antigen 
cross-presentation, an important mechanism of  the immune system 130. 
Nevertheless, certain cells can actively secrete Hsps under a number of 
pathological conditions, implicating the immunity, such as arthritis 131, 
multiple sclerosis 132, diabetes 133 and COPD 70,71. Particularly, Hsp60, is 
released in response to stress and is correlated with the number of 
neutrophils present in the bronchial mucosa of patients with stable COPD, 
suggesting that this chaperonin plays a role in controlling neutrophil 
functions and bronchial inflammation in these patients 65.  
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Based on these considerations, the aim of this thesis was to find a further 
correlation between the chronic inflammation in COPD and Hsp60, which 
acts as a cytokine perpetuating inflammation.  
To achieve this goal, we have considered three possible models to study: 
1) in vivo model, using bronchial specimens obtained from smokers and 
non-smokers, to evaluate the differences in Hsp60 levels and localization; 
2) in the in vitro model we have induced the oxidative stress, a hallmark of 
COPD mucosa, by smoke, in order to determine whether Hsp60 was up-
regulated or down-regulated and if it was, consequently, secreted in 
extracellular space; 3) ultimately, the ex vivo, an organotypic  model, was 
established, where we were able to recapitulate the organization and the 
interaction of cells in EMTU, in order to study the smoking-induced stress 
and verify its effects in the in vivo-like system. Moreover, we have 
reproduced the cross talk between bronchial mucosa and immune system, 
highlighting the key role of the extracellular Hsp60, which is strictly 
involved in chronic immune system activation. 
In preliminary data of this work, represented by our in vivo model, we not 
found significant differences in Hsp60 levels between non-smokers and 
smokers. Conversely, in a previous work, in which biopsies of COPD 
patients were used, the Hsp60 levels were higher in severe/very severe 
COPD compared to control smokers with normal lung function 
65
. 
A proteomic analysis of rats lung exposed to smoke shows that Hsp60 is 
one of the most altered proteins, together with proteins that regulate 
apoptosis, stress response, cell structure, and inflammation 134. The 
function of these proteins ensures the homeostasis maintaining, although 
when they are overexpressed, are strictly associated to cell transformation 
134.  
The results obtained demonstrate the dissimilar modulation of Hsp60 in 
our different models. Particularly, 16-HBE cells did not show significant 
variations in Hsp60 levels and localization. These data were consistent 
with those obtained in our in vivo model. On the other hand, such result 
are not in accordance with previous data where the exposure of 16-HBE 
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cells to oxidant and pro-inflammatory stress, H2O2-induced, caused the 
upregulation of Hsp60 and the release of this chaperonin in the 
extracellular medium 65. This discrepancy could be due to the different 
stimulus used, which could activate different pathways, involved in 
response to stress. We used different doses of CSE for different time-
points and probably immortalized cells were able to overcome the stress 
induced by CSE, activating other pathways. Moreover, the complexity of 
CS, which is a mixture of components, induces a complex of biological 
responses, involving an enormous number of signalling pathways. 
Furthermore, we hypothesize that the mechanism of immortalization has 
influenced the Hsp60 function in these cells.  
Conversely, in mucoepidermoid cancer cell line (H292), we showed an 
increase of Hsp60 levels and this protein was exported outside of the cell, 
in response to sub-lethal doses of CSE. Furthermore, it has already been 
demonstrated that Hsp60 increased in cancerous tissue and is liberated in 
circulation 97,135. Hsp60 is present mostly in the cytoplasm and 
extracellular sites of cancer cells rather than normal cells 136–138, and 
moreover, this protein is present in the plasma membrane, where it could 
serve as a ligand for immune system cells 139,140. The relation between 
smoking, COPD, and lung carcinogenesis is still an open field of 
investigation; in fact, each inhaled insults could cause the metaplasia and 
thus cell transformation and cancer 141.       
Here, the possible pathway involved in Hsp60 secretion has been 
investigated focusing in on exosomes secretion. Hsp60 is physiologically 
secreted in the extracellular space by a mechanism which is independent 
of cell death, as a consequence of cell-cell communication or depending 
on the pathological condition. The results obtained in a previous work of 
our laboratory, it has been demonstrated that Hsp60 can reach the cell 
membrane and is released by exosomes in tumor cells (H292) but not by 
normal cells (16-HBE) 81. The data obtained from the in vitro model of this 
thesis are in accordance with these previous results while the new finding 
is that Hsp60 was actively secreted also after CSE exposure. Therefore, 
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following the stress induced by smoke, Hsp60 is overexpressed and 
released into the extracellular environment where it can acts as a danger 
signal inducing stress or damage of the cells or it can promote the 
immunological escape of cancerous or pre-cancerous cells 142,143.  
It has been reported that Hsp60 has a key role in immune-modulation, 
since activates human monocytes and macrophages to synthesize pro-
inflammatory cytokines (such as TNFα, IL-12, IL-15) and nitric oxide, also 
synergizing with IFN-γ in inducing cytokine synthesis 144,145. This effect is 
mediated by binding to Toll-Like Receptor (TLR) 2 and 4, which induce the 
NFkB-dependent signalling pathway leading to cytokine secretion. 
Based on the data obtained using the in vivo and in vitro models, we 
studied the effect of CSE on the morphology of our ex vivo model, 
mimicking COPD, focusing on Hsp60 levels and its release after smoke 
exposure. The in vitro models, currently used, are a monolayer epithelial 
cell culture and often are not useful to reproduce the events occurring in 
vivo, resembling only partially the human bronchial epithelium. 3D models, 
instead, have a high degree of similarity with human lung tissue. The 
bronchial 3D outgrowths, in particular, have a high potential to reproduce 
the real morphology and functions of EMTU, allowing the study of the 
cellular responses in a setting that resemble in vivo environments. This is 
a suitable model to investigate the oxidant effects induced by CS and 
drugs and therapeutic molecules finding as well.  
In this study, the smoke effects on human bronchial mucosa were 
evaluated after mid- to long-term exposures to CSE, in order to highlight 
the response to the chemical constituents of CSE that relate to oxidative 
stress. CSE induces a variety of macroscopic morphological changes, as it 
has previously been characterized 146,147. The bronchial mucosa 
undergoes epithelial-mesenchymal transition (EMT) in which cells lose cell 
polarity, and the columnar epithelium become squamous; loss of the 
ciliated cells and a thickening of the basement membrane is observed. 
These modifications are typical in the remodelling of bronchial mucosa in 
COPD. Moreover, downregulation of cell adhesion proteins, specifically 
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the tight junctions, has been also observed allowing migratory and 
invasiveness capabilities. These events has been seen in our ex vivo 
model, by direct observation (phase contrast microscopy monitoring), 
TEER measurement and immunofluorescence for ZO-1 protein (tight 
junctions) 120,148,149. Indeed, our model was able to reproduce most likely 
the tissue changes typical of the mucosa in COPD.     
In the present work, it has also been confirmed that CSE induces 
apoptosis in the bronchial mucosa, although a previous work, in 
monolayer in vitro model, has showed that smoke-induced cell dead could 
be mediated by the Apoptosis Induced Factor (AIF) 150.  
Interestingly, when bronchial 3D outgrowths were treated with low doses 
of CSE, the TEER appeared to be higher than in the untreated cells. 
Probably, low doses of CSE induce activation of growth and survival 
factors, described previously in fibroblast, which could be responsible for 
increased cell proliferation and fibrosis in COPD mucosa 151. Moreover, it 
has been shown that CSE activates NFkB, which could regulate the cell 
survival following smoke-induced DNA damage 152.    
In the literature, there are several studies about the relation between Hsps 
and smoke 153 in particular it has been reported the role of Hsp70 71,154,155, 
while few studies take in account the involvement of Hsp60 156. At the best 
of our knowledge, this is the first study which analyses the effect of smoke 
on Hsp60 expression in an organotypic model. The data, obtained in our 
3D model suggest that the increased levels of Hsp60 after the acute 
treatments with CSE might represent a cytoprotection effect. It is well 
established that Hsp60 overexpression in various cell lines protects from  
the oxidative injury, suppressing mitochondrial membrane permeability 
and inhibiting apoptotic and necrotic cell death 157. However, after a 
chronic stimulation (7 and 21 days) of the 3D outgrowths, we observed a 
decrease of Hsp60 gene and protein levels. Probably, the modulation of 
Hsp60 expression is related to cell transformation and carcinogenesis that 
could occur in this model as described previously in bronchial biopsies 
from COPD and lung cancer patients 141.  
Expression and Localization of “Chaperokine” Hsp60 in Bronchial Culture 
Models Miming COPD 
 2013/15
 
96 
 
In response to CSE treatment, the bronchial 3D outgrowths secrete Hsp60 
in the extracellular environment probably without using the exosomal 
pathway, since Hsp60 was not detected in the exosomes preparation.  We 
demonstrated that the levels of extracellular Hsp60 were higher in a dose- 
and time-dependent mode, suggesting an extracellular signalling role of 
this chaperonin. Hsp60 might play a role as immune modulator, as 
demonstrated previously due to its capacity to interact with both the innate 
and adaptive immune system 158, 159.  
To further elucidate the extracellular functions of Hsp60, we have 
investigated if there was a correlation between the levels of Hsp60 and the 
levels of cytokines, released by the 3D outgrowths exposed to smoke. We 
found a significant correlation between Hsp60 levels and IL 8 and -1β, 
while Hsp60 negatively correlated with IL 2, -10, -13, -4 and GM-CSF. It is 
interesting to note that Holz and colleagues, demonstrated that after 
airways inflammation IL 1β, -6 and -8 were significantly increased 160. 
Additionally, the cytokine IL-8 was significantly increased only in bronchial 
epithelium of patients with severe/very severe COPD compared with 
control healthy smokers 161. Bronchial cells exposed to smoke secrete 
high levels of IL 8, as demonstrated by Moon and colleagues 162. Taken 
together these observations and our findings, we can assert that Hsp60 
expression could be correlated with the inflammatory state of COPD since 
it has been already demonstrated that the levels of this protein has been 
related to the number of inflammatory cells in the mucosa of COPD 
patients 65.       
In order to find out if our data can be translated in vivo, we have analysed 
the levels of Hsp60 in the plasma of COPD patients, compared with those 
of healthy donors. As expected, the circulating levels of Hsp60, in COPD 
patients, were higher than in controls confirming the results obtained ex 
vivo. Hence, Hsp60 could be used as biomarker to monitor COPD 
pathogenesis and the inflammatory response involved in this disease.  
An increasing number of scientific papers demonstrates the function of 
molecular chaperones as an extracellular signal 57, and in particular of 
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Hsp60 96,143,163,164 even if the significance of the cell–cell signalling through 
the Hsps is still under debate 158,159.  
In our model, Hsp60 appears to be secreted in conventional mode, 
independent from exosomal pathway. For this reason, we decided to 
mimic  Hsp60 capability to interact and activate human monocytes using a 
commercial recombinant Hsp60 (rHsp60) and exosome released from 3D 
outgrowth exposed to smoke. The cytokine levels in the conditioned 
medium of the monocytes co-cultures were higher when treated with 
rHsp60 compared to exosomes treatment confirming monocytes activation 
and the hypothesis that Hsp60 could be considered as a cytokine-like 
molecule. We found that after rHsp60 stimulation IL 1β and IL 7 levels 
were higher compared to the controls and there was a positive correlation 
between IL 1β and IL 7 levels with Hsp60 levels in plasma of COPD 
patients. These two cytokines are chemotactic and growth factors which 
stimulate cell proliferation and differentiation of macrophages and 
lymphocytes, respectively. Taken together these data strengthen our 
hypothesis and only few studies considered Hsps as monocyte cytokine 
inducers because the difficulties founded in the experimental methods and 
statistical analyses 165,166. The extracellular behaviour and the effect of 
Hsp60 on the target cells could depend of the stimulation of a number of 
signalling pathways involving cytokines gene transcription and could give 
molecular response difficult to understand.     
Final remarks.  
To summarise the data obtained and described in this thesis, we have 
found that Hsp60 levels did not show significant differences between 
smokers and non-smokers, in the in vivo study. In the in vitro model, we 
observed that Hsp60 is subjected to variation in levels and distribution, in 
H292 cancer cell line but not in normal cells, demonstrating the correlation 
between smoke and lung cancer. This relation was also established in the 
ex vivo model, in which a CS-induced remodelling characteristic of the 
epithelial-mesenchymal transition occurred. We showed that our ex vivo 
model is useful to reproduce the morphological and functional changes in 
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bronchial mucosa exposed to smoke. Indeed, we observed, for long-time 
exposure to smoke, an intracellular reduction and, contemporary, an 
extracellular increase in Hsp60 levels, suggesting that Hsp60 might be 
released from the smoke-stressed human mucosa into the circulatory 
torrent. Here, this chaperonin could be able to act as a chemokine at 
distant site triggering the activation of the immune system and 
perpetuating the inflammatory response in the bronchial mucosa. This was 
demonstrated by the correlation between Hsp60 with the cytokines IL 1β 
and IL 8 released from 3D outgrowths exposed to CSE and by the 
correlation between Hsp60 with the cytokines IL 1β and IL 7 released from 
PBMC stimulated with Hsp60. 
Taken together these observations and results suggested that Hsp60 
represents a new biomarkers for diagnostic and prognostic purposes in 
COPD management as well as in other inflammatory chronic disease.  
The prospective for new therapies, together with a deeper analysis of 
molecular events and the possible modulation of Hsp60 activation and 
releasing pathways, needs to be further studied. 
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